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Abstract 
Biologically relevant cell culture assays that can be adapted for high-throughput 
screening are very important for biopharmaceutical industry. Cellular material for such 
applications can represent static cultures that do not change over time, or dynamic (i.e. 
transformational) cultures based on pulripotent cells undergoing “cellular metamorphosis” and 
differentiating into a multitude of various descendant cell types – the process accompanied by 
formation of histologically complex tissues. Hydrogels being hydrophilic polymer-based 
adhesion matrices promote tissue-like microenvironments through tunable mechanical qualities 
and presentation of bioactive molecules. Moreover, hydrogel-based implants with controlled 
geometry can also be used for stem cell delivery and other therapeutic applications.  
This thesis investigates how main cell functions can be controlled by the matrix 
mechanical properties, with a goal to emulate physiological processes in vitro and potentiate 
stem cell treatments with appropriate bio-matrix design. First, I describe a method to promote 
advanced cardiomyogenic and endothelial differentiation within embryoid bodies through the 
control of three-dimensionality on collagen-polyacrylamide gels with tunable stiffness (Chapter 
2). Next, the function of airway smooth muscle cells is investigated on substrates with 
physiological and pathological stiffnesses as it pertains to the cell adhesion, proliferation, 
calcium signaling and secretory function (Chapter 3). And finally, the impact of inner geometry 
is studied in cell-laden alginate based bio-patches designed to promote recovery of blood 
perfusion in a mouse model of hind limb ischemia (Chapter 4). The results of this thesis will be 
useful in attempts to recreate tissue environment in vitro for toxicity assays and in cell-based 
therapies of ischemic conditions via cell-laden-scaffold implantation.  
 
iii 
 
Acknowledgements 
 
My journey to a completion of this work was made possible by great people whose 
influence on me was much more significant than I originally anticipated, and therefore, I would 
like to thank at least some of them who directly and indirectly were involved with me during my 
career. Briefly, I would like to thank my first professor of anatomy Dr L. P. Kovshikova and the 
professor of anatomical pathology and former rector of Veterinary Academy in Vitebsk 
(Republic of Belarus) Dr M. S. Zhakov, both of whom cultivated in their students, including 
myself, the love for the profession they taught notwithstanding the dire conditions that followed 
the economical collapse of their country. Only now I am realizing that they finally solidified my 
intention to become biomedical scientist.  
Next, I am in great debt to Dr E. S. Manuilova for her contribution to my understanding 
of mouse embryonic stem cell biology during my days at the Institute of Molecular Genetics in 
Moscow, Russia. Next, Dr Yury Verlinsky, the director of the Reproductive Genetics Institute 
and my home in Chicago for nearly 6 years, who brought me overseas, and was brave enough 
not only open up the treasures of a new country before my eyes but also had no angst to rush into 
an emerging field of human embryonic stem cell research and take me with him. Many hours of 
our conversations made me much more open-minded and not afraid of adhering to my 
convictions.  
I enjoyed biopsy read-outs with my residency coordinator professor Matthew Wallig, 
after he must have found some potential in me and accepted into a combined residency/PhD 
program here, at the University of Illinois at Urbana-Champaign. Our long discussions have been 
crucial for my understanding of professional terminology related to anatomical pathology, 
toxicology and (surprise!) world history. And of course, I am especially indebted to my PhD 
adviser, Professor Hyunjoon Kong, who offered me this position in his laboratory at a time when 
iv 
 
my future was foggy and exposed me to a new area of biomaterials and biomedical devices.  
Even though it must have been hard for him to have “a hard-entrenched biologist” in his lab, Dr 
Kong provided me with necessary support and advice and pushed to finish what I started. I 
would like to thank my other two graduate committee members Professors Mark Kuhlenschmidt 
and Marie-Claude Hofmann for help with so many seemingly “unsolvable” issues.  
I also would like to express my gratitude to my fellow residents at the Department of 
Pathobiology and lab mates in Dr Kong’s laboratory who educated me without knowing it: 
Rommel Max Tan, Tony Cappa, Sandeep Akare, Raju Mantena, Luke Borst, Patrick Roady, 
Arnon Gall, Min Kyung Lee, John Schmidt, Nihan Yonet Tanyeri, Kwanghyun Baek, Max Rich, 
Ross DeVolder, Mei-Hsiu Lai, Cartney Smith, Nick Clay, and Cathy Chu. I appreciate the 
training I received from the University of Illinois Department of Animal Resources staff: 
Margaret Clabaugh, Jamie Ludwig, Jesse Southern, and Chris Learned; and Institute of Genomic 
Biology Core Facility imaging specialists,  Mayandi Sivaguru and Donna Epps: modern imaging 
techniques definitely have made my future life “brighter”. I feel thankful to Ms Karen Reed, 
histotechnologist of the Veterinary Diagnostic Lab, who patiently helped me with sectioning and 
staining of embryoid bodies and other tissues. The staff of the Department of Pathobiology office 
Linda Rohl, Paula Moxley and Julie Haferman deserves special thanks for their help with grant 
applications and tremendous amounts of paperwork involved.  
My parents, Alexander Shkumatov and Lyudmila Lipchanskaya stayed with me through 
ups and downs of my career, I am thankful for their unconditional love. And finally I am very 
thankful for my very supportive wife, Tatiana. Hardly would I have been able to complete this 
work without your love and advice.  
v 
 
In addition to the above, I must acknowledge the financial support from the Department 
of Pathobiology residency program support, which made this work possible. 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
Table of Contents 
Chapter 1: Introduction  ......................................................................................... 1 
1.1. Cellular Assays in Biopharmaceutical Industry .............................................................1 
1.2. Overview of Hydrogel Materials and Scaffolds ..............................................................2 
1.3. Overview of Mechanical Stiffness Measurement Techniques .......................................9 
1.4. Overview of Mechanical Stiffness of Human Tissues ...................................................10 
1.5. Overview of Cell Behavior on Matrices with Varying Stiffness ..................................13 
1.6. Overview of Cells used in Pharmaceutical Industry ....................................................17 
1.7. Overview of Tissue Ischemia Treatment Strategies .....................................................21 
1.8. Conclusions and Project Overview.................................................................................22 
1.9. References .........................................................................................................................24 
 
Chapter 2: Matrix Rigidity-Modulated Cardiovascular Organoid Formation 
from Embryoid Bodies .......................................................................................... 30 
 
2.1. Introduction ......................................................................................................................30 
2.2. Methods and Materials  ...................................................................................................33 
2.2.01 Preparation of hydrogels ........................................................................................33 
2.2.02 Analysis of hydrogel stiffness ..................................................................................34 
2.2.03 Undifferentiated embryonic stem cell culture .........................................................35 
2.2.04 Embryoid body (EB) culture ...................................................................................35 
2.2.05 Histological analysis ...............................................................................................36 
2.2.06 Total RNA purification ............................................................................................36 
2.2.07 Real time PCR .........................................................................................................37  
2.2.08 Immunohistochemical imaging ...............................................................................37  
2.2.09 Cell cycle analysis...................................................................................................38 
2.2.10 Morphometric analysis ...........................................................................................38 
2.2.11 Statistical analysis ..................................................................................................38 
2.3 Results ................................................................................................................................39 
2.3.01 Assembly of EB-adherent hydrogels with controlled elastic moduli ......................39 
2.3.02 Effects of matrix stiffness on growth and microstructure of EBs............................40 
2.3.03 Effects of matrix stiffness on cardiomyogenic and endothelial differentiation and  
          subsequent cardiovascular tissue-like structure within EBs ...................................45 
2.3.04 Analysis of cardiomyoblast proliferation within EBs .............................................48 
2.4 Discussion ...........................................................................................................................50 
2.5 Conclusion ..........................................................................................................................54 
vii 
 
2.6 References ..........................................................................................................................56 
 
Chapter 3: Mechanical Stiffness of the Matrix Impacts Airway Smooth 
Muscle Cell Proliferation, Calcium Signaling and Secretory Function ........... 58 
 
3.1 Introduction .......................................................................................................................58 
3.2 Materials and methods .....................................................................................................60 
3.2.01 Preparation of hydrogels ........................................................................................60 
3.2.02 Analysis of hydrogel stiffness ..................................................................................61 
3.2.03 Cell culture..............................................................................................................61 
3.2.04 Staining for actin.....................................................................................................62 
3.2.05 Immunocytochemical analysis ................................................................................62 
3.2.06 Analysis of cell proliferation ...................................................................................63 
3.2.07 Intracellular [Ca
2
]i imaging  ..................................................................................63 
3.2.08 Human VEGF ELISA ..............................................................................................63 
3.2.09 Morphometric analysis ...........................................................................................64 
3.2.10 Statistical analysis ..................................................................................................64 
3.3 Results ................................................................................................................................65 
3.3.01 Preparation of collagen-conjugated polyacrylamide gels with controlled rigidity 65 
3.3.02 Effects of Egel on cellular adhesion .........................................................................66 
3.3.03 Effects of Egel on intracellular calcium transport ...................................................67 
3.3.04 Effects of Egel on cellular proliferation ...................................................................68 
3.3.05 Matrix stiffness-dependent cellular VEGF secretion ..............................................70 
3.3.06 Effects of Egel on integrin β1 expression .................................................................71 
3.4 Discussion ...........................................................................................................................73 
3.5 Conclusion ..........................................................................................................................77 
3.6 References ..........................................................................................................................79 
 
Chapter 4: Angiogenic Patch for Stem Cell Delivery  
into Ischemic Hind Limb ....................................................................................... 82 
 
4.1 Introduction .......................................................................................................................82 
4.2 Methods and Materials .....................................................................................................84 
4.2.01 RGD peptide conjugation to alginate .....................................................................84 
4.2.02 Fabrication of alginate hydrogels ..........................................................................85 
4.2.03 Encapsulation of IFN- γ in alginate hydrogel.........................................................85 
4.2.04 Cell encapsulation into gel disks  ...........................................................................86 
4.2.05 Human VEGF ELISA ..............................................................................................87 
4.2.06 Surgical procedure..................................................................................................87 
4.2.07 Laser Doppler perfusion imaging ...........................................................................88 
viii 
 
4.2.08 Histopathology ........................................................................................................88 
4.2.09 Immunohistochemistry ............................................................................................88 
4.2.10 Morphometric and statistical analysis ....................................................................89 
4.3 Results ................................................................................................................................91 
4.3.01 Gels with anysotropically aligned pores ................................................................91 
4.3.02 MSC distribution in the gels ...................................................................................92 
4.3.03 VEGF release from gels in vitro .............................................................................93 
4.3.04 Perfusion recovery ..................................................................................................94 
4.3.05 Assessment of revascularization .............................................................................96 
4.3.06 Implant histopathology ...........................................................................................98 
4.4 Discussion .........................................................................................................................100 
4.5 Conclusion ........................................................................................................................104 
4.6 References ........................................................................................................................105 
 
Chapter 5: Summary and Future Directions ................................................ 108 
 
5.1 Summary ..........................................................................................................................108 
5.2 Future directions .............................................................................................................109 
5.3 References ........................................................................................................................112 
 
 
1 
 
Chapter 1: Introduction 
1.1 Cellular Assays in Biopharmaceutical Industry 
Cell-based assays are critical for drug discovery and development of novel therapeutics, 
especially at the early stages of the drug development process. Cell cultures in combination with 
high throughput screening are indispensable for high content analysis (HCA) and advanced cell 
models, which have been created in an effort to maximize biological relevance of in vitro 
studies. HCA uses cell culture assays for target identification, early screening of compounds, 
lead selection and optimization, which are all necessary steps for a selection of a candidate drug.  
The data obtained with the use of cellular assays is essential for determination of potential 
efficacy and safety of drug candidates. Cell-based assays are an invaluable source of information 
for change in morphology and cellular functions as a response to novel chemical entities and 
biomaterials. Today, there is a great need for reliable and efficient cell culture models that could 
accelerate drug development and be ideally suited for high-throughput compound screening. This 
need for high throughput screening has been necessitated by recently increased costs of new drug 
development in the pharmaceutical industry and extended time period that is now required to 
bring new drugs to the market. According to the Eli Lilly’s website, the cost of developing a new 
drug was 1.3 billion US dollars in 2012; however, this amount does not account for all 
unsuccessful and discontinued drug candidates. On average, it takes about 12 years to develop a 
new drug molecule and successfully complete clinical trials [1]. This is a very long period of 
time for someone who has a currently incurable condition and is in great need for efficient 
medicines now. Moreover, many industry leaders believe that all easy targets for drugs have 
been exhausted [2], and to make major breakthroughs in drug discovery new technological 
approaches are needed. In the beginning of the last decade the Food and Drug Administration 
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was approving about 100 new drug molecules every year. Since then this number has been cut 
more than four-fold [2].  
Because clinical trials (phase I through phase III) are the most expensive stages of drug 
development, much effort is directed at eliminating unpromising candidates at the early stages, 
preferably even before the preclinical phase. Preclinical stages of drug development incorporate 
expensive and ethically controversial animal tests. Because of their often prohibitively high costs 
and unresolved ethical issues, currently there are increased efforts to reduce the amount of work 
that involves animals and animal models. Although it will be impossible to completely eliminate 
animal studies, attempts could be done to make in vitro tests more predictive and reliable in 
order to partially satisfy the needs of pharmaceutical industry. Most in vitro tests involve cell 
cultures in two-dimensional (2D) environment, usually in culture flasks or Petri dishes, where 
cells grow in monolayers on very stiff surface (plastic). However, in 2D culture, there is a 
paucity of cell-to-cell contacts, and cells are far removed from all chemical and mechanical cues 
that represent the complexity of three-dimensional (3D) natural tissue environment. Several 
sources have reported that 3D cell cultures significantly differ from cell monolayers and are 
advantageous over conventional 2D cell growth [3-4]. Furthermore, three-dimensional cell 
culture environment allows to create growth conditions that accurately mimic the natural 
behavior of cells and can be an important step for improving predictive test accuracy in drug 
discovery [4].  
 
1.2 Overview of Hydrogel Materials and Scaffolds  
Current methodology that allows for creation of an environment resembling the tissue of 
interest in vitro involves the use of hydrogels. Hydrogels are a highly branched natural or 
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synthetic polymers and hydrophilic materials that can incorporate hundreds of times more water 
than its own weight. Originally hydrogels were used in contact lenses, and later for drug delivery 
devices and cell encapsulation vehicles [5-6]. Now hydrogels are actively used for emulation of 
three-dimensional tissue environments, because their physical characteristics (e.g. mechanical 
stiffness and swelling ratio) can be easily modulated by varying the density of cross-links in 
vitro. The synthesis of hydrogels can occur under mild processing conditions that allow both 
seeding of cells on the surface of the hydrogels as well as within the hydrogels.    
Because hydrogels resemble extracellular matrix (ECM) environment of normal tissues, 
they are very popular for tissue engineering purposes and for regeneration studies. Hydrogels are 
characterized by tissue-like flexibility and possess viscoelastic properties, interstitial fluid flow 
and diffusion rates similar to real animal tissues [7]. Hydrogels represent scaffolds that provide 
certain chemical (adhesion sites) and physical (mechanical stiffness) cues to incorporated cells 
and protect or modulate cell behavior. Some of the important characteristics of hydrogels are the 
following: type of biomaterial, porosity, pore size, pore interconnectivity, geometry and 
mechanical properties (tensile strength and mechanical stiffness). Biocompatibility and 
biodegradability are important for hydrogels used as implants in vivo. The controllable nature of 
above-mentioned hydrogel properties makes hydrogels invaluable for re-creation of an 
environment in vitro close to that of normal tissue. Depending on their origin, hydrogels can be 
divided into natural and synthetic. Natural hydrogels are derived from plant or animal tissues, in 
contrast to synthetic hydrogels, which are produced by de novo synthesis, usually from 
petroleum and its products.  
Natural hydrogels are attractive scaffolds because they consist of purified components of 
natural extracellular matrices, and often already contain cell adhesion sites on their polymeric 
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chains. The similarities between naturally-derived polymers and the native ECM often lead to 
excellent interactions between the cells of interest and the scaffold. Natural scaffolds are often 
biocompatible and biodegradable, which makes them irreplaceable for cell transplantation 
studies. Many natural polymers have been used for modeling of three-dimensional environment 
in vitro, including collagen, fibrin, gelatin, chitosan, hyaluronic acid and alginate.  
A good example of a plant derived natural hydrogel is alginate (alginic acid), which is an 
anionic polysaccharide manufactured from the cell walls of gray algae. Alginate scaffold is 
composed of homopolymeric blocks of (1-4)-linked β-D-mannuronate and its C-5 epimer α-L-
guluronate covalently linked together in different sequences or blocks (Fig. 1A) [8]. 
Polymerization of alginate scaffolds is induced by divalent cations, for example calcium, that 
cross-links the polymeric chains. Recently, alginate scaffolds have been widely used in human 
medicine for transplantation of encapsulated pancreatic islet β-cells [9-10]. The quality that 
makes alginate very attractive for cell encapsulation is its inert nature, which prevents the 
adsorption of proteins on its surface. This makes alginate a very biocompatible material that 
induces minimal immune responses in host tissues after implantation. Therefore, islet cells 
encapsulated in alginate microspheres become shielded from immune cells and can function for a 
long time, since alginate hydrogels are easily penetrable by oxygen, water and nutrients [10]. 
Alginate scaffolds also have found its application in toxicity testing of new drug candidates. 
Because hepatotoxicity is a major concern in pharmaceutical industry, a novel 3D alginate-based 
system has been created with hepatocyte-derived HepG2 cells as a detection component. This 
test platform has facilitated the evaluation of drug dose concentrations to predict hepatotoxicity 
and its effects on the target cells. In vitro 3D test platforms like this can be adapted for multiple 
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cell types in hybrid settings, which then may be used for screening of new chemical entity 
compounds [11].  
 
Figure 1. Chemical structure of component molecules of alginate and poly(lactic-co-glycolic acid) (PLGA). (A) 
Alginate is a gray algae-derived polysaccharide composed of homopolymeric blocks of β-(1-4)-mannuronic acid and 
α-(1-4)-guluronic acid. (B) PLGA is formed during random opening and copolymerization of two polymeric 
molecules glycolic acid and lactic acid. Images reproduced from www.kimica-alginate.com and www.azonano.com 
 
A significant drawback of alginate-based scaffolds, however, is the absence of cell-
controlled enzyme systems for alginate degradation. This makes it impossible for cells to break 
down the matrix and significantly expand cell populations. Alginate also lacks specific 
mammalian cell adhesion sites. However, the modification of alginate is possible with various 
cell adhesion peptides, and the density and sequence of such adhesion sites can vary. One of the 
most common cell adhesion peptides incorporated into alginate scaffold is arginine-glycine-
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aspartic acid (RGD). However, there are numerous types of adhesion peptides that can be used 
for the induction of adhesion by different cell types and to various hydrogel biomaterials (Table 
1) [12].   
Peptide Source Cell adhesion 
molecule 
Cells 
DGEA Collagen 1 α2β1 Vascular SMCs 
RGD Collagen 1, 
thrombospondin, 
osteopontin, 
fibronectin, 
vitronectin, 
Integrins Mesenchymal and 
epithelial cells 
KRSR ECM glycoproteins Heparin/Heparan 
sulphate 
Rat osteoblasts 
WQPPRARI ECM glycoproteins Heparin/Heparan 
sulphate 
Endothelial cells 
 
Table 1: Examples of most commonly used cell adhesion peptides. 
 
 Collagen is a main component of fibrous connective tissue in animals and the most 
abundant protein in mammals, contributing to about 30% of total body content [13]. Collagen is 
composed of a triple helix that forms as a result of polymerization (Fig. 2). It is over-rich in three 
specific aminoacids: proline, hydroxyproline and glycine. Collagen polymerization is a thermal 
reaction that efficiently runs at pH > 6.5, which is compatible with tissue pH. Collagen gels are 
an excellent scaffold that provides cell adhesion sites and can support a variety of different cells 
types [14]. However, collagen is a fragile material, and collagen-based scaffolds often possess 
low physical strength. Moreover, collagen scaffolds usually contract when placed into a living 
animal. Contraction of collagen in vivo is due to the presence of fibroblasts, which are the 
driving force of this phenomenon. This drawback may not affect the use of collagen in in vitro 
tests, but can be very inconvenient when used for in vivo studies seeking to regenerate tissue. 
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Collagen does not hinder cell population expansion, because it can be degraded by 
metalloproteases naturally secreted by the mammalian cells.                
 
Figure 2. Spatial structure of collagen fibers. Three most common amino acids in the chemical structure of 
collagen I α-chains: glycine, proline and hydroxyproline. The presence of lysines allows cross-linking of collagen 
molecules. The image is reproduced from www.sp.uconn.edu. 
 
 
 Although less commonly used for cell culture than their biological counterparts, synthetic 
hydrogel materials are very attractive as scaffolds because they allow controlling a wider range 
of physical properties that modulate cell behavior. Synthetically produced matrices are 
chemically pure, contain no unknown contaminants of biologically active molecules and growth 
factors, and are simple to prepare and synthesize. Such scaffolds can be used in a variety of ways 
8 
 
due to a practically unlimited number of engineering options. The main disadvantage of synthetic 
hydrogels is their low biological relevance compared to biologically-derived matrices, and the 
absence of signaling molecules and sequences, which extracellular matrix naturally provides. 
Synthetic hydrogels include polyacrylamide-based hydrogel, poly(lactic-co-glycolic acid) or 
PLGA, poly(ethylene glycol) or PEG, poly(2-hydroxyethyl methacrylate) (pHEMA) and others 
[15-22].  
 Polyacrylamide hydrogel deserves its recognition for modeling natural tissue 
environments because it is characterized by easily quantifiable elastic properties that can be 
promptly adjusted by changing the concentrations of its monomer acrylamide and the cross-
linker bis-acrylamide. Polyacrylamide gels, while devoid of adhesion sequences and molecules, 
can be functionalized with components of natural extracellular matrix, for example collagen I 
[15]. Cells, however, cannot grow into the polyacrylamide gels and enter the substrate because 
polyacrylamide gel surface has pore size around 100 nm, which is too small for cells or cell 
processes (pseudopodia). Because of the inert nature of polyacrylamide gels, only negligible 
amounts of protein and serum can be absorbed by the polymer backbone ruling out non-specific 
reactions between the gel and the biological object [23]. Moreover, the clear and translucent 
characteristics of polyacrylamide make it indispensable when fluorescent/ confocal microscopy 
is used for assessing effect of a treatment on cells [24].  
 Poly(lactic-co-glycolic acid) (PLGA) is another favorite biodegradable synthetic scaffold 
because of its easily controlled degradation rates, physical qualities (especially, toughness) and 
easy fabrication and modification (Figure 1B). PLGA is a porous scaffold that contains pores of 
controlled diameter for cell localization. Scaffolds such as PLGA can be molded into a variety of 
shapes that resemble the architecture of natural human organs, including external ear, bones or 
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hollow tubes and vessels [25-26]. Porous scaffolds with excellent mechanical properties, such as 
PLGA, are especially useful for regenerative medicine where the synthetic matrix is designed to 
maintain structural integrity of an implant until the incorporated cells can produce enough ECM 
of their own and completely overtake the function of ECM production and remodeling in a local 
environment [25]. PLGA also can serve as a material for manufacturing of drug-encapsulated 
microparticles for local stem cell or drug delivery [17, 22].  
 The design of various synthetic and natural hydrogels and scaffolds seeks to emulate the 
properties of natural tissue environment including its mechanical characteristics, with 
mechanical stiffness being by far the most important. Tissue rigidity has a profound impact on 
cell behavior, expression profile, movement and adhesion as will be discussed on the following 
pages.  
 
1.3 Overview of Mechanical Stiffness Measurement Techniques  
 Mechanical stiffness of tissues is measured by determining their elastic moduli, which is 
a mathematical description of an object’s resistance to deformation by a force. The slope of the 
stress-strain curve in the deformation area defines the elastic modulus of an object. Therefore, 
stiffer materials are characterized by a higher elastic modulus [27].  
E =
      
      
 
where E is the elastic modulus of an object, stress is the force of a deformed object wishing to 
return to its previous un-deformed state per unit of area, and strain is the ratio of the changed 
state due to stress relative to the intact state of the object. Elastic modulus is measured in Pascals. 
Elastic modulus of relatively stiff hydrogels (E > 1000 kPa) is measured by compressing the gels 
using mechanical testing machine. In this case, normal stress is applied to the tested material that 
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is perpendicular to the direction of force. In contrast to that, the measurement of the elastic 
modulus of very soft hydrogels requires the use of a rheometer, which is a device that helps to 
determine how fluids or very soft materials (slurry) act in response to an applied force. 
Rheometers use shear stress to measure the mechanical stiffness of an object. In contrast to 
normal stress, shear stress is directed parallel to the surface of the tested object/ hydrogel. Shear 
stress is a parameter that is used for calculation of the shear modulus in soft hydrogels, for 
example fibrin and collagen gels [28].  
 
1.4 Overview of Mechanical Stiffness of Human Tissues  
Extracellular matrix (ECM) provides mechanical support as well as biological and 
biophysical signals to the cells incorporated into it. One of the most important characteristics of 
ECM is its mechanical stiffness, in other words the hardness of the adhesion matrix. Cells not 
only adhere to matrix but also exert a “pulling” force on the matrix substrate, which deforms the 
matrix in accordance with its elastic properties. Mechanical stiffness is characterized by elastic 
modulus (E). Soft substrates are easily deformed, in contrast to stiff matrices, which are resistant 
to deformation. Elastic modulus is measured in units of force applied per units of area (Pascals) 
(Figure 3). Mechanical stiffnesses of human tissues vary from very soft brain and fat (E = 1 kPa), 
to intermediate muscles and heart (E = 10 - 20 kPa) to very hard decalcified bone (E = 50 - 60 
kPa) [15].  
Tissue rigidity is defined by the sum of the elastic modulus of the cells and the elastic 
modulus of the ECM. However, the ECM plays a greater role in shaping tissue rigidity [29]. One 
needs to discriminate between the bulk elastic modulus that measures the mechanical stiffness of 
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the entire tissue and ECM components and the mechanical stiffness of individual 
  
Figure 3: Schematic describing cell interactions with the matrix. Cells can sense the deformation of the 
matrix and respond appropriately. Elastic modulus is a mathematical description of the mechanical stiffness.  
 
components, for example, individual collagen I fibers or fibroblasts [29]. There is often no 
possibility to assess the elastic moduli of individual tissue components, therefore, the great 
majority of studies report only bulk elastic moduli for various tissues. The value of measurement 
may also depend on the method used to measure the mechanical stiffness. The most common 
technology applied today is atomic force microscopy (AFM) microindentation [30].  It allows 
measurement of focal tissue elastic modulus using an appropriate AFM indenter, cantilever and 
indentation depth under guidance of phase contrast and fluorescence microscopy of the examined 
area of interest.  
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 Tissue rigidity can vary in normal and pathological conditions. For instance, local 
deposition of fibrous ECM proteins (collagen 1) in fibrosis after tissue injury leads to a 2 - 4 fold 
increase in mechanical stiffness in affected tissue [30]. For myocardium, this means an increase 
from E = 10 - 20 kPa to E = 40 - 75 kPa, which results in the impairment of contractile activity 
of individual cardiomyocytes [31]. The change in mechanical stiffness of vessels can be quite 
significant in a diseased state: the elastic modulus of vascular wall rises from around 30 kPa in 
norm to 80 kPa in a rabbit model of atherosclerosis [32]. Stiffening of vascular walls in 
atheroscleosis leads to the decreased vascular compliance and increased cardiac pressure 
overload. Resulting effect is hypertension and myocardial hypertrophy in affected individuals. In 
contrast to vessels, there is paucity of information on mechanical stiffness of pulmonary tissue. 
Shear modulus of normal lung was found to be 0.5 kPa; however, lung is composed of different 
constituent tissues including stiff bronchi and more delicate bronchioles and alveolar septa, with 
each characterized by different mechanical properties [30]. Because lung undergoes multiple 
cycles of stretch and relaxation, it is important that natural lung stiffness be preserved. Any 
pathological process can destabilize the fine balance, and for instance, in fibrosis, the rigidity of 
lung parenchyma can rocket 30-fold to 20-100 kPa [33]. Areas of fibrosis in the lung usually 
have multifocal distribution creating very non-homogenous bulks of tissue, where shearing 
forces between hardened foci likely damage healthy tissue, characterized by more delicate 
organization, further exacerbating pathologic process [33].  
 Edema usually leads to rarefaction of tissue ECM and a decrease in tissue mechanical 
stiffness in non-enclosed spaces, such as skin or lung [29]. However, any edema or inflammation 
in the brain, which is confined within a closed calvarium, dramatically changes the stiffness from 
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less than E = 1 kPa to approximately E = 20 kPa [34]. Activation of astrocytes regulating water 
balance in brain neurons can occur when elastic modulus reaches only 0.5 kPa.  
 Organs are composed of numerous components including cells and ECM, each with its 
own rigidity. The combination of all tissue constituents’ elastic moduli comprises the bulk elastic 
modulus. However, more often cells change their function in response to change in mechanical 
properties of the local matrix to which they are directly adhered rather than to a generalized 
change. On the following pages, more light will be shed on how cells respond to localized 
mechanical stimuli under conditions of natural environment or when adhering to an artificial 
scaffold in vitro.  
 
1.5 Overview of Cell Behavior on Matrices with Varying Stiffness 
Mechanical stiffness of the ECM has a profound effect on cell behavior and function. 
Cells often secrete ECM components in response to local stumuli (for example, chronic 
inflammation-induced deposition of collagen [35]), and in turn, cells also modulate their 
behavior depending on the focal composition of the matrix. ECM is mostly composed of 
adhesive glycoproteins, proteoglycans, glycosaminoglycans and fibrous proteins that also 
incorporate biologically active molecules and growth factors. Until recently, cell biology was 
mostly focused on biological signaling cues mediated by small or large organic molecules and 
overlooked the greater impact exerted by the physical properties of the cellular environment. 
Most cellular models used today are based on cell cultures growing on very hard plastic surfaces 
with E = 1 GPa. When growing on a stiff substrate that cannot be deformed, cells acquire 
unnatural flattened morphology, have exaggerated proliferation rates and show differences in 
cancer drug sensitivities [36-37]. Stiffer substrates induce higher levels of expression of adhesion 
14 
 
molecules, for example integrins [38], facilitating stronger adhesion to the substrate. Moreover, 
expression profiles differ when cells are grown on stiff substrates [39]. This is partially explained 
by an increase in the synthesis of cellular structural proteins, such as actin [34]. The 
overabundance of structural proteins in cells on stiff substrates is necessary for strengthening the 
cytoskeleton under the conditions of increased mechanical stress. On softer substrates cells 
acquire a plump or rounded morphology, with only a few focal adhesions and relatively few 
actin fibers. Such arrangement allows the cell to promptly undergo deformation in accord with 
the deformation of the surrounding soft matrix and compensate for the over-distension of the soft 
matrix (Fig. 4)[34]. By contrast, stiff matrices cannot be deformed to the same degree as soft 
matrices; however, existing shearing forces can be more damaging because of a rigid structure. 
Therefore flattened morphology, with the expression of abundant structural proteins, such as 
actin, and many focal adhesions, serve as an adaptation to withstand mechanical shear stress in 
stiff tissues. The cells are able to sense the mechanical signals sent by the matrix and adjust their 
function accordingly. However, the importance of mechanical sensing becomes obvious in some 
types of cancer where cells lose their ability to assess the rigidity of the matrix and increasingly 
die causing local necrosis sometimes as a result of inability to withstand mechanical damage 
(Fig. 4) [34]. Thus, in the process of tissue growth cells tend to adapt to the matrix rigidity by 
changing their own mechanical stiffness.                         
 In response to changing matrix rigidity, cells also adjust their own stiffness via synthesis 
of structural proteins. A good example of a lesion related to inability of a cell to control its own 
mechanical stiffness is in HIV-associated nephropathy. This condition is accompanied by a loss 
of podocytes, dilation of glomerular capillaries and ultimately focal segmental 
glomerulosclerosis. Podocytes in this condition withdraw their foot processes and prematurely 
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degenerate leaving glomerular capillaries without a protective sheath. The loss of podocyte 
function is due to decrease in cellular stiffness from 17 kPa in normal to around 4 kPa in     
                                
Figure 4: Schematic representing mechanical sensing in health and disease (Janmey et al., Journal of Cell Science 
2011, 124: 9-18). 
diseased podocytes, as measured by atomic force microscopy [40]. The dramatic reduction in 
podocyte rigidity is accompanied by a decrease in expression of filamin and synaptopoidin, and a 
reduction in the amount of stress fibers.  Thus, in a healthy tissue, cells maintain different 
rigidities that support their function. In the previous example, podocyte rigidity was significantly 
higher than the reported rigidity of normal fibroblasts (E ~ 17 kPa in podocytes versus 5-12 kPa 
in fibrooblasts) [40-41]. Such difference may be necessary for normal podocytes, with their 
complex system of foot processes, to maintain their structure and function, including the 
filtration slits (diaphragm slits) that prevent large proteins and cells from passing into the urinary 
space.  
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Rigidity of matrix has a great impact on how cells spread, adhere, proliferate, and migrate 
[23, 34, 42]. Moreover, the matrix stiffness determines how cells differentiate and assemble with 
each other. The majority of epithelial and mesenchymal cells spread significantly better on stiff 
substrates, which is manifested through a larger total cell adhesion area and often higher cell 
aspect ratio, which is a ratio of the long cell axis to its short axis. Larger spreading area is also 
accompanied by the formation of prominent actin stress fibers in rigid environments [42]. On 
soft matrix (E ~ 1 kPa) fibroblasts and epithelial cells form relatively few dynamic “tentative” 
focal adhesions, which are irregular and punctuate in nature [43]. In contrast, stiffer substrates (E 
~ 100 kPa) induce formation of stable arrays of focal adhesions and promote phosphorylation of 
focal adhesion kinase and paxillin, indicating the presence of an intracellular response in reaction 
to the stiffness of the substrate.  Increased numbers of focal cell adhesions on rigid matrices lead 
to much stronger adhesion to the matrix [44]. Intracellular sensing of elevated matrix rigidity 
leads to the activation of mechanisms responsible for increased proliferation in multiple normal 
and neoplastic cell types [45-46]. The increase in proliferation rates under the conditions of rigid 
ECM may be used by several forms of  cancer that induce strong desmoplastic response of the 
stroma and the deposition of stiff collagen 1 fibers augmenting the malignant nature of the 
neoplastic process [47-48]. Pancreatic carcinoma is a good example of such a cancer [49]. In 
other words, an increase in proliferation by cells on a stiff matrix is a physiological response of 
many normal cells to an increase in mechanical stiffness, which is also exploited by some 
cancers. In cancers, induced by very anaplastic and dedifferentiated cells, there is a loss of 
sensitivity to external mechanical stimuli [34]; and cells often pile on each other forming 
multilayered sheets in vitro rather than migrate out onto the unoccupied stiff matrix. Moreover, 
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highly anaplastic cells can proliferate in the absence of adhesion to any surface, because anoikis 
(cell death by detachment) in such cells is inhibited [50].   
Additionally, cell migration has been found to be dependent on matrix stiffness in several 
cell types, including fibroblasts and smooth muscle cells [51-52]. These cells migrate towards a 
matrix that has increased rigidity, a phenomenon named durotaxis [53]. Durotaxis demonstrates 
that cells sense physical stimuli provided by matrix in ways similar to chemoattractants.    
Durotaxis is likely responsible for disassembly of the three-dimensional tissue environment 
when tissue explants are cultured on very hard plastic Petri dishes in vitro. Guo et al. 
demonstrated that the cells migrated out of heart explants placed on rigid matrix [54], but there 
was no cell migration out of heart explants if the explants were cultured on softer matrices. 
Findings such as this may be very useful for creation of in vitro models of three-dimensional 
tissues.  
Substrate stiffness has a great effect on the differentiation of undifferentiated progenitor 
cells or stem cells. For example, Engler et al. demonstrated that mesenchymal stem cells could 
differentiate into neurons on gels with an elastic modulus of brain (E = 0.1-1.0 kPa), into 
myocytes on gels with an elastic modulus of muscle (E = 8-17 kPa), and into osteoblasts on gels 
with an elastic modulus of decalcified bone (E = 25-40 kPa) [55]. Thus along with providing 
adhesive surface, cell matrix can also be a tool for modeling extracellular environment and 
modifying cellular behavior.  
 
1.6 Overview of Cells used in the Pharmaceutical Industry  
 Modern cell and tissue banks contain many thousands of cell types and lines that can be 
used in research. One needs to differentiate between immortalized cell lines, which can be 
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propagated in vitro for indefinite periods of time, and primary cell cultures, derived from a tissue 
of interest, that can only be maintained in vitro for a limited number of passages. There are also 
disease-specific or genetically modified cell lines particularly useful for discovery stage of drug 
development that focus on target identification and validation and initial in vitro efficacy studies. 
Primary cell cultures with a normal karyotype are widely used for initial safety screening of drug 
candidates. Whereas the virtually unlimited number of pathologic conditions and possible targets 
generates a need for a variety of normal, immortalized and even neoplastic cell lines for drug 
discovery, toxicological studies usually utilize cell lines/ cultures with normal karyotype that 
theoretically should represent tissues/ organs of an average patient. Therefore, an ideal cell type 
for toxicological studies is a uniform cell population with a normal karyotype that can proliferate 
for a long time in vitro and produce quantities large enough to provide cellular material for 
repeated studies that can be standardized throughout the pharmaceutical industry. The majority 
of cells used currently in industry is derived either from fetal tissues or adult humans, and can be 
expanded in vitro for no longer than 5-40 cell doublings.  
 Cardiotoxicity is a major adverse reaction to any potential new drug compound, a 
situation that usually leads to a termination of the study. To detect cardiotoxicity at an early 
stage, human immortalized cardiomyocyte cell lines and animal fetal cardiomyocytes have been 
used for toxicity testing; however such models may have low predictive accuracy [56]. Using 
human primary cardiomyocytes could lead to more accurate results, but these cells are 
notoriously difficult to maintain in vitro and their limited supply makes them a poor choice for 
drug safety testing. Therefore, new cell sources are constantly being sought, and recently, human 
embryonic stem cells (hESCs) have come to the fore as a reliable cellular model useful for 
toxicological testing in industry [57]. HESCs can provide unlimited numbers of cardiomyocytes 
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with normal karyotype that are easily maintained in vitro. Such cultures can be standardized and 
used for safety testing of drugs. The use of hESCs is hindered by many ethical problems; 
therefore, induced pluripotent cells (iPS cells) have been invented by reprogramming of somatic 
cells from individual patients with genetic constructs or using specific proteins [58-59]. At some 
point in time, induced pluripotent cells may be able to replace hESCs in drug testing, when the 
problems associated with their incomplete reprogramming and heterogeneity will be overcome 
[60]. Moreover, characterization of the genetic background makes it possible to test for adverse 
drug reactions in certain human populations using such cell cultures, bringing personalized 
medicine even closer to the beginning of the drug design process.  
 Hepatocytes present another cell type that is successfully used in industry for 
toxicological research, because liver is a primary organ for metabolism of drugs and 
detoxification of toxicants. Toxicity can be assessed by cell viability after the drug is added into 
the culture medium. Moreover, the impact on hepatocyte function can be evaluated by measuring 
such endpoints as the release of albumin and urea and induction of cytochrome P450 enzyme 
activity. Most commonly, such models involve tests done on primary human hepatocytes [61]. 
However, recently hepatocytes derived from induced pluripotent cells have been introduced into 
pharmaceutical industry [62]. Maturation level of these cells is sufficient to use in toxicological 
studies.  
 Smooth muscle cells (SMCs) have become a focus of attention in toxicological 
assessment because they regulate the diameter of blood vessels and airways; and SMCs are 
actively involved in pathogenesis of hypertension, atherosclerosis and asthma [63-68]. Primary 
adult SMC cultures can be expanded in vitro for as long as 5-10 passages that is sufficient for the 
discovery stage during drug development. Smooth muscle cells can be induced to proliferate by 
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multiple cytokines, such as transforming growth factor β, platelet derived growth factor and 
cigarette smoke [32, 64]. SMCs very actively participate in paracrine regulation and secrete an 
array of growth factors and cytokines, including vascular endothelial growth factor (VEGF) [63]. 
 All above-mentioned cell cultures are static, i.e. they are composed of a single cell type 
that does not change over time. In contrast to that, there are also mixed cell cultures that have 
found application in tissue engineering for recreation of complex tissue environment and organ/ 
tissue development in vitro [69-70]. Recently, dynamic or transformational cell cultures have 
drawn a lot of attention [71]. Dynamic systems are based on the inherent property of pluripotent 
cells to spontaneously unfold their differentiation potential and transform into an organ-like 
structure with a complexity of cell types and architectural detail. Whereas the use of these cells 
in tissue engineering and regenerative medicine has been limited, pharmaceutical companies are 
actively exposing pluripotent cell culture systems to vigorous testing, with a goal to advance 
biologically relevant cell culture assays suitable for high-throughput screening [72]. The main 
advantage of dynamic cell cultures is that they involve the use of a single cell type, e.g. 
embryonic or induced pluripotent stem cells, but allow collection of data from multiple endpoints 
based on all differentiated derivatives present following the addition of screened compound into 
the culture medium. A library of gene expression profiles characteristic for multiple groups of 
drugs/ toxins could be developed and used for the prediction of drug toxicity using multi-cell 
screening assays. Potentially dynamic cell culture systems could accelerate or even replace 
embryotoxicity testing currently done on animals.  
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1.7 Overview of Tissue Ischemia Treatment Strategies 
 Normal blood circulation is crucial for all functions of the human organism, because 
blood supplies tissues with oxygen and nutrients and removes toxic wastes. Under normal 
conditions, oxygen and nutrients can spread by diffusion as far as several hundreds of 
micrometers from the blood vessel. Therefore, the smallest blood vessels (i.e. capillaries) are 
spaced 100-200 micrometers apart in all tissues. When blood supply to an organ is cut or 
significantly reduced, local tissue ischemia can develop leading to hypoxia.  Today ischemia can 
be considered a major life threatening complication and a sequel to an array of human diseases, 
especially in developed countries. For example in the United States, more than 5 million people 
were affected with peripheral artery disease (PAD) in 1999-2000 [73] – the cause of acute or 
chronic limb ischemia. In severe cases, PAD can lead to gangrene and a loss of the affected limb 
[73].  
 An active search for modern and effective ways to treat damage after local ischemia is 
ongoing, and there are certain successes achieved in human patients via gene therapy [74-75].  
Also, the delivery of vascular endothelial growth factor (VEGF), basic fibroblast growth factor 
(FGF2) and injections of fibrin have been attempted, to induce local angiogenesis [76]. A 
combination of a biomaterial implant with gene therapy has produced significant improvement in 
a model of hind limb ischemia in mice [77]. In addition, the transplantation of various human 
cells, such as whole bone marrow cells, bone marrow mononuclear cells, hematopoietic stem 
cells, and endothelial progenitor cells for long-term delivery of VEGF into ischemic site has 
been recently attempted [78-79]. As of today, human msenchymal stem cells came to the fore as 
a leader for treatment of PAD [80]. The main advantage of this cell source is a wide variety of 
angiogenic factors, secreted by MSCs, including VEGF [81].  
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 Overall new approaches to build vasculature in an ischemic site are always needed and 
sought for. In PAD, treatment strategies should target arteriogenesis, because there is a lack of 
large caliber blood vessels capable of carrying large amounts of blood to the lower extremities. 
Modern technology has facilitated the growth of different models that provide endpoints testable 
by magnetic resonance imaging, computed tomography, Laser Doppler perfusion imaging that 
are indispensable in pro-angiogenic research. 
 
1.8 Conclusions and Project Overview 
 Creation of biologically relevant cell culture systems is an important goal that can 
significantly increase productivity in biopharmaceutical industry through the advancement of 
high-throughput screening. Moreover, appropriate models can be adapted for patient specific or 
individualized medicine, where tumor explants could be cultured and tested in vitro in order to 
produce a proper customized medication regimen on an individual basis. Gradual shift towards 
three-dimensional or 3D-like culture systems that emulate natural physical properties of human 
tissues will help to better understand cell function in natural environment.  In this case, hydrogels 
as highly pliable materials will serve to model physiological conditions in vitro and regulate 
three-dimensionality of resulting cell aggregates. The combination of dynamic pluripotent cell 
cultures with hydrogel matrices may become the most effective strategy for growth of organoids 
for both toxicity testing and tissue engineering.  The three-dimensionality of such organ-like 
structures can be tuned by a change in the mechanical stiffness of hydrogel matrix that would 
balance out outward and inward migration of cellular constituents. Measurable endpoints will 
need to be established for toxicological assays based on dynamic cell cultures; and gene 
expression profile and morphometric image analysis will complement each other. Besides the 
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mechanical stiffness, inner structure of hydrogel matrix (matrix geometry) has an effect on main 
functions of cells, and has to be taken into account when designing novel man-made matrices. 
Biomaterial scaffolds should be able to maintain a favorable microenvironment and protect 
transplanted cells from the host immune system and hostile inflammatory cytokines.  
 Several novel approaches to tissue regeneration have been investigated in my PhD thesis, 
which will be addressed in Chapters 2-4. In Chapter 2, physical properties of collagen-
polyacrylamide gels have been modeled, with a goal to induce the formation of organoids from 
embryoid bodies (EBs), characterized by advanced cardiomyogenic and endothelial 
differentiation through the regulation of three-dimensionality of EBs via change in matrix 
mechanical stiffness. Next in Chapter 3, main cell functions, such as adhesion, spreading and 
proliferation, and integrin β1 expression, calcium signaling, and VEGF secretion are investigated 
in human airway smooth muscle cells with the aim of better understanding of asthma 
pathogenesis. And finally in Chapter 4, there is a discussion of the role of inner geometry in an 
experiment to design a pro-angiogenic alginate based cell-laden biopatch for recovery of blood 
perfusion in a mouse model of hind limb ischemia.  Chapter 5 summarizes my thesis research 
and lays out future directions for each of the three projects.  
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Chapter 2: Matrix Rigidity-Modulated Cardiovascular Organoid Formation 
from Embryoid Bodies 
 
2.1 Introduction 
In a course of natural developmental and regeneration process, cells play essential roles 
in forming complex tissues and organs via controlled proliferation, differentiation, and secretion 
of extracellular matrix molecules.  For several decades efforts have been made to better 
understand and further regulate these activities by orchestrating cell interactions with the 
extracellular matrix and neighboring cells.  In these efforts, cells are often cultured to form a 
cluster [1-2].  Such cell clusters can be further directed to form complex multicellular 
conglomerates in vitro towards generation of complex, three dimensional (3D) organoids useful 
for fundamental and applied bioscience studies. 
Multicellular clusters are typically prepared by inducing aggregation between multiple 
types of tissue-specific cells suspended in culture medium or embedded in 3D gel matrices; 
however, this approach is often plagued by a limited cell source, poor controllability of spatial 
organization of cells, or the need for overly complex formulation of cell culture medium.  For 
that purpose, embryoid bodies (EBs), derived from embryonic stem (ES) cells, have been 
extensively studied, because pluripotent ES cells can unlimitedly generate desired tissue-specific 
cells via self-renewal and differentiation processes.  For example, a medium supplemented with 
certain soluble factors, including retinoic acid and DMSO, stimulated cardiomyogenic 
differentiation in EBs [3-4].  Separately, a method was established to stimulate differentiation to 
Flk1 positive endothelial progenitor cells in EBs [5].  However, there is still a need to improve 
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differentiation levels and finally create multicellular clusters with structure and functionality 
similar to tissues of interest.  
According to recent studies, mechanical rigidity of a matrix, to which cells adhere, plays 
a significant role in regulating cellular phenotypes because cells are able to sense and respond to 
changes in their mechanical environment [6].  For instance, the differentiation of mesenchymal 
stem cells into a specific lineage is enhanced on a matrix designed with stiffness similar to the 
tissue of interest [7].  In addition, a cell adhesion matrix with heart tissue-like stiffness (i.e., 
elastic modulus of 6-10 kPa) was shown to facilitate contraction/relaxation of cardiomyocytes, 
whereas a scar-like stiff substrate prompted cells to lose their contractile activity [8].  Therefore, 
it is plausible that mechanical stiffness of a cell adhesion matrix may modulate multidirectional 
differentiation of ES cells within EBs and affect further function of resulting organoids; 
however, to date few efforts have been made to systematically examine the role of matrix rigidity 
in tissue differentiation.   
Embryoid bodies are formed from ES cells grown in suspension on low adhesion culture 
dishes and present an intermediate stage for ES cell differentiation. ES cell differentiation into 
EBs is a spontaneous process that is regulated by spatiotemporal arrangement of cells. The cells 
lining the EB surface belong to the primitive endoderm lineage, which gives rise to yolk sac in 
true embryos, whereas cells inside EBs represent populations of mesodermal, ectodermal and 
definitive endodermal origin.   Unlike previously believed, EB differentiation is not random, but 
resembles early gastrulation events in embryos, and thus, resembles the natural process of 
development [9-10]. Interestingly, an early attachment to the matrix was found to be crucial for  
prolonged embryo development in vitro on collagen gels in true mammalian embryos [11]. 
Similarly, EB attachment to the matrix destroys radial symmetry, orients EBs and establishes 
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bilateral symmetry that subsequently leads to the induction of mesoderm [12], and therefore, 
may ultimately promote myocardial differentiation.  However, substrates with high mechanical 
stiffness (1GPa) have been found to transform three-dimensional (3D) cell arrangement in EBs 
into a two-dimensional monolayer of cells on culture plastic [12]. Thus, we have hypothesized 
that a high mechanical stiffness of substrate and a relative paucity of cell-to-cell contacts may be 
inhibitory for myocardial and endothelial differentiation. 
In this study, we hypothesized that modulating the mechanical stiffness of a matrix to 
which EBs adhere would allow us to regulate cellular cardiomyogenic and endothelial 
differentiation within EBs and further modify the cellular ultrastructure and contractile activity 
of resulting organoids.  To examine this hypothesis, EBs derived from ES cells were cultured on 
a pure collagen gel or collagen-conjugated polyacrylamide (CCP) hydrogels with elastic moduli 
of approximately 0.2, 6, and 40 kPa.  After culture for 23 days, cellular differentiation and 
intercellular organization were examined using immunostaining and histological techniques.  
Additionally, the contractile activity of resulting cardiovascular organoids was examined by 
analyzing their beating frequency.  Overall, this study has led to a better understanding of the 
emergent behavior relevant to cardiovascular tissue development and regeneration.   
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Figure 5. Schematic describing preparation of collagen-conjugated polyacrylamide (CCP) gels. Collagen-
conjugated PEG acrylate was mixed with pre-gel solution of acrylamide, bis-acrylamide, and ammounium 
persulfate, in order to link collagen to polyacrylamide “backbone” in a hydrogel.   
 
2.2 Methods and Materials 
2.2.01 Preparation of hydrogels 
  The collagen gel was prepared by reconstituting bovine type I collagen solution (PureCol, 
Advanced Biomatrix) with cold DMEM/F12 (Invitrogen). The final concentration of collagen 
was kept constant at 1.4 mg/ml.  The resulting collagen gels were incubated at 37 
o
C and 5% 
CO2 for two hours before plating EBs. Separately, to prepare collagen-conjugated 
polyacrylamide gels (CCP) with different elastic moduli (Fig. 5), 3 mg/ml collagen solution was 
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first incubated with 50 mg/ml poly(ethylene glycol) N-hydroxy succinimide ester (Acrylate 
PEG-NHS, Jenkem Technology) in ratio 10:1 at 4 
0
C for two hours.  Then, the collagen bound 
with acrylate PEG-NHS was mixed with stock solutions of 40% acrylamide and 2% N,N′-
methylenebis(acrylamide), and finally with 10% ammonium persulfate (Sigma) and 10% 
tetramethylethylenediamine (TEMED, Fluka).  The molar ratio between 2% N,N′-
methylenebis(acrylamide) and acrylamide was varied from 0.0017 to 0.017. The resulting gel 
was further incubated in phosphate buffered saline (PBS) at room temperature overnight before 
plating EBs on the gel.  PBS was exchanged three times a day.  All gels including pure collagen 
gels remained structurally stable throughout the entire culture period (15 days). 
 
2.2.02 Analysis of hydrogel stiffness 
  Mechanical stiffness of the resulting CCP gels was evaluated by measuring the 
compressive elastic moduli of the gels. After 24 hours of incubation in PBS, gels were 
compressed at a rate 0.1 mm/min using a mechanical testing system (MTS Insight, Laboratory 
for Biomaterials and Tissue Engineering). The compressive elastic modulus was calculated from 
the slope of the curve between stress and the first 10% of strain. Three samples were measured 
per condition. Separately, shear modulus of the pure collagen gels was measured using a 
rheometer. The collagen gel was prepared by reconstituting bovine type I collagen solution 
(PureCol, Advanced Biomatrix) with cold DMEM/F12 (Invitrogen) to a final concentration 1.4 
mg/ml. The samples were prepared within the space between the walls of a rheometer’s cup and 
bob (Bohlin; CD-50). Then, the samples were oscillated at a stress from 0.02 to 5 Pa to deform 
the gel in the linear viscoelastic region. The frequency was varied from 1 to 10 Hz. 
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2.2.03 Undifferentiated embryonic stem cell culture 
 In all experiments, the mouse embryonic stem cell line W4 (Taconic) with passage 
numbers between 17 and 22 was used.  The undifferentiated state was maintained by culturing 
cells in 85 % DMEM/F12 (Mediatech, CellGro
R
) and 15 % Knockout Serum Replacement 
(Invitrogen) on a mitomycin-treated mouse embryonic fibroblast feeder cell monolayer [13].  
The medium was also supplemented with 0.1 mM 2-mercaptoethanol (Invitrogen), 1:100 
GlutaMAX
TM
 (Invitrogen), and 1000 U/ml mouse leukemia inhibitory factor (Sigma).  ES cells 
were re-plated on gelatin (Sigma)-coated dishes 3 days before harvesting them to prepare EBs.  
 
2.2.04 Embryoid body (EB) culture 
  Undifferentiated ES cell colonies were dissociated by incubating them in a 0.05% trypsin 
solution (Mediatech).  The dissociated cells were placed on polystyrene-based six-well cell 
culture plates and incubated in differentiation medium with or without serum.  Differentiation 
medium was composed of 90% DMEM/F12 (Mediatech), 10% fetal bovine serum (FBS, Gibco), 
0.1 mM 2-mercaptoethanol (Invitrogen), 1:100 GlutaMAX
TM
 (Invitrogen), 100 U/ml penicillin, 
and 100 μg/ml streptomycin. In serum-free medium, FBS was substituted with Knockout Serum 
Replacement (Invitrogen).  The six-well culture plates (Becton Dickinson) were placed on a 
rotary shaker (Heidolph Rotamax 120) at 30 rpm and incubated at 37
0
C and in 5% CO2 without 
interruptions. After four days, EBs were transferred into 25 cm
2
 flasks treated with 2.3 % agar 
(Sigma) and cultured for another four days. On Day 8, all EBs were split into four groups: EBs 
cultured in suspension, EBs plated on a collagen gel with an elastic modulus of 0.2 kPa, and on 
collagen-conjugated polyacrylamide gels with elastic moduli of 6 and 40 kPa.  
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2.2.05 Histological analysis 
 After EBs were fixed in 10% buffered formalin for four hours and embedded in paraffin, they 
were sectioned into 3 m thick sections.  The sections were stained with Hematoxylin and Eosin 
(H&E), and photographed with a NanoZoomer Slider Scanner/ Digital Pathology System 
(Hamamatsu). Areas filled with uniform eosinophilic cellular debris, with lost differential 
staining of nuclear and cellular details were recognized as areas of necrosis. Fraction of necrotic 
cells in histological sections was quantified by counting numbers of positively stained pixels 
using NIH ImageJ software [14].  
 
2.2.06 Total RNA purification 
 EBs were briefly treated with a 0.025% solution of collagenase 1 (Sigma) for 
detachment from the substrate and washed once with PBS. Total RNA was extracted using an 
RNeasy© Mini Kit (Qiagen,) according to the manufacturer’s instructions. The tissue was 
disrupted and homogenized by vortexing and using a syringe with 20G needle.  The 
concentration of RNA was measured using a spectrophotometer (ND-1000, NanoDrop); and the 
quality of RNA was confirmed with 2100 Bioanalyzer (Agilent).  
 
2.2.07 Real time PCR  
cDNA was synthesized from equal amounts of total cellular RNA using random hexamer 
primers and the SuperScript® III First-Strand Synthesis System (Invitrogen) as per 
manufacturer’s instruction. The amplification of cDNA was performed on the Applied 
Biosystems 7900HT Fast Real-Time PCR System. Molecular Probes Assays (Mm00473657_m1 
and Mm01290256_m1, Invitrogen) were used for amplification of Actn2 and Tnnt2 mRNA, 
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respectively. The reaction was carried out at 50 C for 2 min, 95 ºC for 10 min, then at 95 ºC for 
15 sec and at 60 ºC 1 min for 40 cycles.  For each sample, PCRs were performed in duplicate or 
triplicate. The cDNA levels were determined using the standard curve of cycle thresholds. The 
results were normalized against the mouse GAPDH cDNA (Molecular Probes Assay ID: 
Mm99999915_g1).   
 
2.2.08 Immunohistochemical imaging 
EBs were collected on Day 23, fixed in 10 % buffered formalin for one hour, and 
incubated in 0.5% Triton X in PBS at 4 ºC overnight. Then, EBs were blocked in PBS with 3% 
bovine serum albumin for two hours and stained overnight with primary antibodies against CD31 
(Abcam, ab28364) and against sarcomeric -actinin (Abcam). EBs were washed three times with 
PBS before exposure to secondary antibodies: goat anti-rabbit IgG (H+L) (DyLight 488, 
ThermoScientific) and polyclonal Alexa Fluor® 568 Goat anti-mouse IgG (H+L) (Abcam). After 
overnight incubation at 4 ºC, EBs were washed three times and mounted on glass slides with 
mounting medium Prolong
R
 Gold Antifade Reagent (Invitrogen).  Mounted EBs were flattened 
into disks with thickness 20-30 μm on the slides. Finally, EBs were imaged using a laser 
scanning confocal microscope (Zeiss LSM 700).  Specifically, sarcomeric α-actinin was imaged 
by exciting samples at 555 nm and collecting emission over 560 nm.  CD31 was imaged by 
exciting samples at 488 nm and collecting emission ranging from 488 nm to 550 nm. Positively 
stained area in individual EBs was quantified using NIH ImageJ software.  
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2.2.09 Cell cycle analysis 
 Proliferating cells in EBs were labeled with Click-iT® EdU Alexa Fluor ® 488 Imaging 
Kit following manufacturer’s instruction. In brief, EBs were incubated with EdU for 24 hours 
and fixed on days 15 and 25. In parallel, cardiomyocytes within EBs were stained for sarcomeric 
α-actinin as described above. Cell nuclei were marked with 4',6-diamidino-2-phenylindole 
(DAPI) in the final concentration 5 μg/ml. Again, EBs were imaged using a laser scanning 
confocal microscope (LSM 700, Zeiss), with at least 1000 cells counted for each group.  
 
2.2.10 Morphometric analysis 
NIH ImageJ software was used for all morphometric analyses of EBs. EB diameter was 
measured with images captured using an inverted microscope (DMI 4000B, Leica) equipped 
with a digital camera ORCA-ER (Hamamatsu Photonics). The size of embryoid bodies was 
measured by drawing a line along the short axis of an EB. Such measurement characterizes the 
lesser diameter of an EB.  
 
2.2.11 Statistical analysis  
At least three repeats were done for each experimental group; and 50 EBs or more were 
analyzed for each condition unless indicated otherwise.  Statistical significance was determined 
via two-way and one-way ANOVA tests, where p < 0.05. The data is presented with mean ± SE 
unless indicated otherwise.  
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Hydrogel M E (kPa) Q 
Pure collagen gel N/A 0.2 80.9 ± 2.3 
CCP gel 0.0017 6.0 ± 0.8 47.1 ± 1.9 
CCP gel 0.017 40.0 ± 1.1 19.5 ± 1.7 
M: Molar ratio of N,N′-methylenebis(acrylamide) to acrylamide; E: Elastic modulus, Q: Degree of swelling  
Table 2:  Composition and properties of hydrogels used in this study. 
 
2.3 Results 
2.3.01 Assembly of EB-adherent hydrogels with controlled elastic moduli 
 Collagen-based hydrogels capable of inducing EB adhesion on their surfaces were 
assembled to present controlled elastic moduli while keeping collagen density in the gels 
constant. Gels with an elastic modulus (E) 0.2 kPa were prepared by changing the pH of 
precursor collagen solution, with collagen concentration 1.4 mg/ml, to 7.3 (Table 2).  E of the gel 
was further increased to 6 and 40 kPa by introducing mixture of acrylamide, acrylated PEG-NHS 
and varying amounts of bis-acrylamide into 1.4 mg/ml collagen solution and activating in situ 
polymerization and cross-linking reactions.  The acrylated PEG-NHS chemically linked collagen 
to polyacrylamide.  Increasing the elastic modulus of the collagen-polyacrylamide gels resulted 
in a decrease of the swelling ratio (Table 2).  All gels remained structurally stable throughout the 
entire cell culture period, without showing any deformation or structural disintegration.  
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Figure 6: Schematic description of an experimental design. EBs were formed from a suspension of ES cells during 
the first 8 days.  Then, EBs were cultured in suspension or on the pure collagen gel with an elastic modulus  0.2 kPa 
or collagen-conjugated polyacrylamide gels with controlled elastic moduli 6 and 40 kPa for additional 15 days.  
 
2.3.02 Effects of matrix stiffness on growth and microstructure of EBs  
 The design of the experiment is depicted in Figure 6. Embryoid bodies were induced on 
day 0 by culturing ES cells on low adhesive dishes using rotary shaker.  Rotary EB culture 
provided us with large numbers of EBs with circular shape and uniform size. On 8
th
 day EBs had 
an average diameter of 319 ± 19 m (not shown). The continued culture of EBs in a suspended 
state over total 23 days led to a three-fold increase of the average diameter (Fig. 7A and B).  EBs 
adherent onto collagen-based gels displayed a general linear dependency of EB diameter on E of 
the gel, which was more prominent in EBs cultured in FBS-supplemented medium.  Specifically, 
the diameter of EBs cultured on the gel with E of 40 kPa was comparable to that of EBs cultured 
in a suspended state.  There was no statistically significant difference in the average diameter 
between EBs cultured with and without FBS (Fig. 7B).  
 Spatial organization and viability of cells within EBs were further analyzed by staining 
cross-sections of EBs with H & E.  EBs cultured in FBS-free medium were composed of tightly 
packed cells (images in the second row of Fig. 8A) independent of the elastic modulus of the gel; 
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and EB cores contained large necrotic areas largely filled by cells, with lost differential staining 
of nuclei and cytoplasm.  In contrast, EBs cultured in FBS-supplemented medium often 
contained large cavities (cysts) in their cores (images in the top row of Fig. 8A).  According to 
quantitative analysis, there was an almost ten-fold increase of the necrotic area within EBs 
cultured in the FBS-free medium (Fig. 8B).  Additionally, EBs cultured in FBS-supplemented 
medium displayed higher levels of cell organization, such as palisades of epithelial cells, 
epithelium lined cavities, and blood vessels that are major components of different embryonic 
lineages (Fig. 9).   
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Figure 7: Size analysis of EBs cultured in suspended state or on hydrogels with controlled elastic moduli. (A) 
Bright field images of EBs.  (A-1 and A-6) EBs formed by culturing ES cells suspension for 8 days.  (A-2 and A-7) 
EBs cultured in suspended state for additional 15 days.  (A-3 and A-8) EBs cultured on the pure collagen gel with an 
elastic modulus (E) of 0.2 kPa, (A-4 and A-9) EBs cultured on the collagen-conjugated polyacrylamide gel with E of 
6 kPa, and (A-5 and A-10) EBs cultured on the collagen-conjugated polyacrylamide gel with E of 40 kPa.  Images in 
the first and second rows represent EBs cultured in medium supplemented with 10 % FBS and without FBS, 
respectively.  Arrows in A-1 to A-3 indicate cystic EBs. The scale bar represents 1 mm.  (B) The quantified analysis 
of average diameters of EBs cultured in suspended state or on collagen-based hydrogels of controlled elastic moduli.  
Black bars represent the average diameter of EBs cultured in the medium supplemented with 10 % FBS, and grey 
bars represent those cultured without FBS.  Values and error bars represent the mean and standard error of at least 
50 EBs, respectively. The differences between groups were not statistically significant. 
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Figure 8. Histological analysis of EBs cultured in suspended state or on hydrogels with controlled elastic moduli.  
Cross-sections of EBs were stained with Hematoxylin & Eosin. (A)  (A-1 and A-6) EBs formed by culturing ES 
cells in a suspended state for 8 days.  (A-2 and A-7) EBs cultured in suspended state for additional 15 days.  (A-3 
and A-8) EBs cultured on the pure collagen gel with an elastic modulus (E) of 0.2 kPa, (A-4 and A-9) EBs cultured 
on the CCP gel with E of 6 kPa, and (A-5 and A-10) EBs cultured on the CCP gel with E of 40 kPa.  Images on the 
first and second rows represent EBs cultured in medium supplemented with 10 % FBS and without FBS, 
respectively.  Thin arrows in A-2, 3, and 4 indicate cystic EBs. The thick arrow in A-4 indicates columnar 
epithelium, and the arrowhead in A-8 indicates a neuroectodermal rosette. Scale bar represents 250 µm.  (B) 
Quantified necrotic area percentage in EBs cultured in suspension and on hydrogels with E of 0.2, 6, and 40 kPa.  
Black bars represent the average diameter of EBs cultured in medium supplemented with 10 % FBS and grey bars 
represent those cultured without FBS.  The difference of values for EBs cultured in the medium supplemented with 
10 % FBS (black bar) and free of FBS (grey bar) is statistically significant for all four different conditions (*p < 
0.05).   Values and error bars represent the mean and the standard deviation of at least 10 EBs, respectively.  
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Figure 9. Cross-sectional images of embryoid bodies (EBs) stained by Hematoxylin & Eosin.  EBs in (1) to (5) 
were cultured in medium supplemented with 10 % FBS and those shown in (6) to (10) were cultured in FBS-free 
medium. (1 & 6) EBs cultured in a suspended state for 8 days.  EBs were composed of tightly packed immature 
cells. Arrowheads indicate Reichert’s membrane  –  thick basement membrane covered by endodermal cells on the 
external surface. (2 & 7) EBs cultured in a suspended state for 23 days. (3 & 8) EBs cultured on the gel with an 
elastic modulus (E) of 0.2 kPa, (4 & 9) EBs cultured on the gel with E of 6 kPa, (5 & 10) EBs cultured on the gel 
with E of 40 kPa.  In (2 - 4), Cystic EBs display large internal cavity (thin arrows) and outer surface lined by 
columnar epithelium (endoderm) (thick arrows).  In (5), a flattened EB is composed of a multilayered sheet of 
tightly arranged cell with basophilic cytoplasm. In (6), the EB contains well-developed embryonic Reichert’s 
membrane (arrowhead). In (7), the EB shows well-defined necrotic area in the center that contains cellular debris, 
with uniformly pink staining and lost nuclear details. The area of necrosis is circumscribed by a dotted line. In (8), 
the EB displays two neuroectodermal rosettes that are delineated by a dotted line. In (9) and its inset, the image 
shows contractile structure in an EB. In (10), the EB shows an area of necrosis in the center (inset). Scale bars 
represent 50 μm.  
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2.3.03 Effects of matrix stiffness on cardiomyogenic and endothelial differentiation and 
subsequent cardiovascular tissue-like structure within EBs 
The EBs cultured in FBS-supplemented medium exhibited contractile activity from the 
second week of culture.  Interestingly, the percentage of EBs with contractility was seven-fold 
higher on the gel with E of 6 kPa than other three conditions, including EBs cultured in 
suspended state and those adhered to gels with E of 0.2 and 40 kPa (Fig. 10A).  In contrast, only 
a small difference in beating frequency was found between the four groups (Fig. 10B).   
Cardiomyogenic differentiation level was first evaluated by quantifying mRNA levels of 
Actn2 and Tnnt2 genes using real-time PCR. Actn2 and Tnnt2 genes encode sarcomeric α-
actinin (SAA) and cardiac troponin T type 2, respectively, with both being markers of advanced 
cardiomyogenic differentiation in ES cells [15]. The expression of SAA and cardiac troponin 
was significantly elevated in EBs adhered to hydrogels compared to the EBs cultured in 
suspension for the entire period (Fig. 10C and D). There was a slight increase in expression of 
both proteins on the gel with E of 6 kPa, however this finding was not statistically significant as 
measured by qRT-PCR (Fig. 10C and D).  
The cardiomyogenic and endothelial differentiation levels and reorganization of EBs 
were further analyzed with immunostaining for sarcomeric α-actinin (SAA) and CD31, 
respectively (Fig. 11).  It is well reported that EBs do not produce skeletal muscles during 
differentiation, due to the absence of signals from the neural tube and notochord crucial for 
patterning of paraxial mesoderm [16]. Therefore, cells positively stained for SAA were 
considered cardiomyocytes.  Our current staining protocol allowed visualization of all cells 
within EBs after flattening into disks with 20-30 μm thickness and the morphometric 
quantification of different cell types by circumscribing the positively stained areas of EBs.  
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Confocal images of EBs cultured on the gel with E of 6 kPa displayed striated SAA-positive 
cardiomyocyte sheets with distinct CD31-positive blood vessel-like hollow tubes (Fig. 11A - 3, 
7, & 11).  In contrast, EBs cultured on the gel with E of 0.2 kPa showed large fractions of CD31-
positve blood vessel-like hollow tubes and small islands of SAA-positive cardiomyocytes (Fig. 
11A-2, 6, & 10), similar to EBs cultured in a suspended state (Fig. 11A-1, 5, & 9). EBs cultured 
on the gel with E of 40 kPa exhibited smaller numbers of cells positively stained for SAA and 
CD31 (Fig. 11A-4 & 8).   
According to quantitative image analysis, EBs cultured on the gel with E of 6 kPa 
displayed almost a two-fold increase in the percentage of SAA-positive staining, as compared to 
EBs suspended in medium or EBs plated on gels with E of 0.2 and 40 kPa (Fig. 11B).  In 
contrast, the percentage of CD31-positve staining that represents endothelial differentiation level 
was inversely related to the elastic modulus of the gel (Fig. 11C).  Specifically, the decrease in 
the percentage of CD31-positive cells was more considerable as E of the gel rose from 6 to 40 
kPa.   
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Figure 10: Analysis of stiffness-modulated contractions in EBs.  (A) Percentage of contracting EBs. The difference 
of the values between EBs cultured on the gel with E of 10 kPa and other three conditions is statistically significant 
(*p < 0.05).  Values and error bars represent the mean and the standard error of at least 100 EBs, respectively. (B) 
Frequency of EB contractions.  Values and error bars represent the mean and the standard deviation of at least 5 
EBs, respectively.  
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Figure 11. Immunohistochemical analysis of cardiomyogenic and endothelial differentiation within EBs. (A) 
Fluorescent images of EBs stained for sarcomeric α-actinin (red) and CD31 (green).  (A-1, 5, & 9) EBs cultured in 
suspended state for 23 days.  (A-2, 6 & 10) EBs cultured on the pure collagen gel with an elastic modulus (E) of 0.2 
kPa.  (A-3, 7, & 11) EBs cultured on the collagen-conjugated polyacrylamide gel with E of 6 kPa. (A-4 & 8) EBs 
cultured on the collagen-conjugated polyacrylamide gel with E of 40 kPa.  Scale bar represents 200 m.  Images on 
the second row are magnified views of those on the first row.  Images on the third row are three-dimensional 
confocal images of EBs.  (B) Percentage of the EB area positively stained by antibodies to sarcomeric α-actinin.  
The difference of the values between EBs cultured on the gel with E of 6 kPa and other three conditions is 
statistically significant (*p < 0.05).  (C) Percentage of EB area positively stained with an antibody to CD31.  The 
difference of the values between EBs cultured on the gel with E of 6 and 10 kPa is statistically significant (*p < 
0.05).  Values and error bars represent the mean and the standard error of at least 20 EBs, respectively.  
 
2.3.04 Analysis of cardiomyoblast proliferation within EBs  
 The fraction of cardiomyogenic progenitor cells in EBs can be increased by one of two 
mechanism: (1) an increase in cardiomyogenic differentiation level, and (2) an increase in 
proliferation of cells already expressing cardiac markers, such as SAA and cardiac troponin. In 
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order to address the underlying mechanism we assessed effects of gel stiffness on the proportion 
of cardiomyoblasts undergoing cell division. EBs were incubated with 5-ethynyl-2´-deoxyuridine 
(EdU), which is a nucleoside analog of thymidine incorporated into DNA during active cell 
division.  Cardiomyoblasts were identified by positive staining for SAA and incorporation of 
EdU.  According to the EdU assay performed on Days 15 and 23, EBs cultured on the gel with E 
of 6 kPa contained the highest percentage of EdU-positive cardiomyoblasts compared to other 
three conditions (Fig. 12).  Specifically, on Day 23, the percentage of proliferating cells within 
EBs cultured on the gel with E of 6 kPa was almost one-order of magnitude higher than that 
cultured on the gel with E of 0.2 kPa and also 2.5 higher than that cultured on the gel with E of 
40 kPa.   
Interestingly, EBs cultured on the gel with E of 0.2 kPa experienced the greatest drop in 
the percentages of cells undergoing cell division between Day 15 and 23: approximately 15-fold 
decrease.  On Day 23, there was only a minimal percentage of proliferating cardiomyoblasts 
(Fig. 12C).  In contrast, EBs cultured on the gel with E of 6 kPa showed only a 2-fold decrease in 
the number of dividing cells.   
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Figure 12. Cell cycle analysis of cardiomyoblasts using EdU incorporation. (A) Fluorescent images of sarcomeric 
α-actinin positive cells (red) incorporating EdU (green).  Images represent EBs cultured in a suspended state (A-1 
and A-5) and on hydrogels with E of 0.2 (A-2 and A-6), 6 (A-3 and A-7), and 40 kPa (A-4 and A-8). Scale bar 
represents 20 m.  Images on the first row were taken on Day 15, and those on the second row were taken on Day 
23.  (B) Quantified percentage of cardiomyoblasts incorporating EdU on Day 15 (B-1) and 23 (B-2).  In (B-1), the 
difference of values between EBs cultured on the gel with E of 6 kPa and 40 kPa was statistically significant (*p < 
0.05).  In (B-2), the difference of values between EBs cultured on the gel with E of 6 kPa and EBs on the gels with E 
of 0.2 and 40 kPa was statistically significant (**p < 0.05).  (C) The degree of decrease in the percentage of 
cardiomyoblasts incorporating EdU between Day 15 and Day 23. 
 
2.4 Discussion 
 This study demonstrates for the first time that stiffness of a cell-adherent matrix can 
modulate cardiomyogenic and endothelial differentiation of EBs, and further tailor the internal 
structure of cardiovascular organoid. We used rotary culture to produce large numbers of 
embryoid bodies with uniform size and circular shape as was reported previously [1]. EBs 
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attached to the collagen-conjugated polyacrylamide gels with varied elastic moduli (E) exhibited 
active growth in a FBS-supplemented medium with minimal necrosis. Moreover, FBS-
supplemented medium induced formation of cystic embryoid bodies that contained central 
cavities.  EBs also underwent cardiomyogenic and endothelial differentiation, marked by 
sarcomeric α–actinin (SAA) and CD31. However, their differentiation levels were dependent on 
E of the gel in a dissimilar manner.  The number of contractile EBs, the level of cardiomyogenic 
differentiation, and frequency of cardiomyoblasts division were maximal when EBs were 
cultured on the gel with E of 6 kPa.  In contrast, the endothelial differentiation level of EBs 
decreased with increasing E of the gel to 40 kPa.  Therefore, the culture of EBs on the gel with E 
of 6 kPa resulted in contractile EBs incorporating striated cardiac muscle and branched 
endothelial tubes.   
 Results of this study demonstrate that ES cells within EBs can recognize the difference in 
substrate softness, where they actively interact in a three-dimensional environment.  As 
evidenced by a minimal dependency of cardiomyogenic differentiation on stiffness of non-
adhesive collagen-free gels, the insoluble signal of matrix rigidity should be transmitted through 
specific bonds between cellular adhesion molecules (for example, collagen binding α1β1 and 
α2β1 integrins [17]) and collagen. Therefore, it is likely the hydrogel with stiffness of cardiac 
muscle (i.e., E of 6 kPa) biomechanically stimulated ES cells to activate signaling related to 
cardiomyogenic differentiation and proliferation, as confirmed by an increased population of -
actinin positive cardiomyocytes.  This response of cell aggregates to the gel stiffness is similar to 
findings previously made on single cells cultured on gels with varying stiffness [18].  
Additionally, this gel softness must be appropriate to stimulate the proliferation of 
cardiomyoblasts within EBs, as demonstrated by an increased number of EdU-incorporating 
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cells.  We thus suggest that cardiomyoblast proliferation and subsequent differentiation to 
cardiomyocytes generates the largest number of EBs with contractile activity on the hydrogel 
with E = 6 kPa.   
In contrast, the limited cardiomyogenic differentiation of ES cells cultured on the 
hydrogel with softness of brain or fat tissue (i.e., E of 0.2 kPa) indicates that this matrix is too 
soft to transmit an insoluble mechanical signal for cardiomyogenic differentiation to the ES cells.  
Additionally, the limited proliferation of cardiomyoblasts on the very soft hydrogel would be 
another limiting factor towards formation of contracting EBs on such a matrix. This is 
corroborated by an almost 8-fold drop in numbers of EdU-positive cells between days 15 and 23.  
In the super-soft environment cells tend to associate with themselves rather than migrate onto the 
matrix, likely precluding further multiplication via cell contact inhibition.  It is unlikely that the 
reduced cell differentiation was caused by a decreased ligand density on the pure collagen gel 
because the surface density of collagen was adjusted to be identical in all three matrices.  
Therefore, the difference in cardiomyogenic differentiation levels should be largely attributed to 
differences in gel stiffness.   
We also suggest that the decreased cardiomyogenic differentiation in EBs cultured on a 
high E gel mimicking the stiffness of non-mineralized bone matrix (i.e., E = 40 kPa) results from 
a reduction in cell-to-cell contacts due to active cell migration out of the EBs and a disruption of 
the 3D environment as observed.  Similar to previous studies, the stiffer matrix likely activated 
cellular integrin expression, thus reducing intercellular adhesion within 3D EBs.  These changes 
in the cellular organization would result in down-regulation of the process of ES cell 
differentiation into cardiomyocytes.  Additionally, we conclude that reduced proliferation rates 
of cardiomyoblasts on stiff gels recapitulate the natural decrease of proliferation observed in 
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neonatal cardiomyocytes.  It is known that the rise in myocardial stiffness during embryological 
development [19] coincides with the rapid exit from the cell cycle by neonatal cardiomyocytes. 
In mice, the percentage of actively proliferating cardiomyoblasts falls from 23% to 1% between 
embryonic day 14.5 and neonatal day 7 [20]. This marked reduction in proliferative capacity of 
cardiomyoblasts in vivo is surprisingly in line with our findings in the cell cycle altered by the 
gel stiffness in vitro.  
Gene expression analysis performed by qRT-PCR was in general supportive of the 
morphometric analysis. It was reported that gene expression analysis of embryoid bodies is a 
very challenging task.  EBs are composed of various cell types that express housekeeping genes 
at different levels [21]. Therefore, the analysis of ES cell differentiation in EBs is confounded by 
the fact that gels with different stiffness induce proliferation of varying cell populations 
expressing housekeeping genes differently. Expression levels of common housekeeping genes 
HPRT, β tubulin and GAPDH significantly vary in EBs when compared on days 2 and 5 of 
differentiation, with GAPDH being the most stable out of all three [21].  As the duration of our 
experiment was much longer than 5 days, it is likely that the levels of the normalizer gene 
(GAPDH) considerably fluctuated at a time point when morphometric analysis was done. And 
finally, gene expression analysis may be less efficient for detection of less than 3-4-fold 
difference between conditions. Therefore, we propose that morphometric analysis may be more 
appropriate for analysis of the differentiation and cellular EB organization at advanced stages. 
Additionally, we suggest that PCR analysis reflected cardiomyogenic differentiation level of an 
entire EB group without regard for the amount of necrosis or histological integrity of EBs, while 
morphometric analysis allowed us to assess both cellular composition and histological structure 
in individual EBs.   
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We envisage that the bioactive hydrogel matrix with proper stiffness will be useful for in 
vitro assembly and large-scale production of vascularized cardiac tissue that could be used for 
cell therapies in heart disease, in vitro organogenesis and in toxicological assays [22]. Also very 
important is the ability to control the three-dimensionality and inner organization of EBs via 
matrix stiffness for in vitro organogenesis studies. The vascularized cardiac muscle tissue created 
in vitro may be used as a graft for a focal strengthening of the heart wall. Additionally, this study 
will significantly assist efforts to rejuvenate a patient’s own regenerative potential of 
myocardium by elucidating the relationship between physiological hardening of heart muscle 
during development and gradual loss of proliferative capacity in cardiomyoblasts.    Ultimately, 
our findings will bridge fundamental and applied aspects of cardiovascular development, 
pathology, and regeneration and take them to the next level. 
 
2.5 Conclusion 
In conclusion, this study demonstrated the in vitro creation of cardiovascular organoids 
by modulating cardiomyogenic and endothelial differentiation of ES cells in EBs with matrix 
rigidity, coupled with cell adhesion ligands. Specifically, collagen-conjugated hydrogels with 
stiffness similar to cardiac muscle could promote the cell proliferation, cardiomyogenic 
differentiation and, subsequently contractile EB formation, compared to gels with stiffness of 
brain or non-mineralized bony tissue. Therefore, the EB-adherent hydrogel with similar stiffness 
to muscle could create a portion of heart-like tissue, in which striated muscle sheets are 
vascularized with branched blood vessels.  We propose that the results of this study should be 
useful for better understanding of emergent behavior of EBs towards developmental and 
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regeneration process and also extending application of EBs for drug screening, cell therapy, 
tissue regeneration and rejuvenation.   
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Chapter 3: Mechanical Stiffness of the Matrix Impacts Airway Smooth 
Muscle Cell Proliferation, Calcium Signaling and Secretory Function 
 
3.1 Introduction 
Airway smooth muscle cells (ASMCs) are an important component of airways, with 
several significant functions. ASMCs regulate the diameters of airways and adjust them in 
accordance with external or internal conditions, such as overcooling, drying of airways or stress. 
This is important for protection of respiratory function or mobilization of resources in flight-or-
fight response. In addition, ASMCs serve as an irreplaceable source for growth factor release, 
including vascular endothelial growth factor (VEGF), that may be important for the maintenance 
of the vascular capillary bed in lung tissue [1-2]. And finally, ASMCs are actively involved in 
the regeneration of traumatized airways [3]. ASMCs comprise the muscle layer of all airways, 
including trachea and bronchi. Terminal bronchioles lack cartilage and completely depend on 
smooth muscle cell layer to remain patent. Moreover, ASMCs also maintain the integrity of the 
terminal bronchiolar unit that ends in several respiratory bronchioles, which contain alveoli in 
their walls supported by alveolar rings also composed of ASMCs.  
The most common response to airway injury by ASMCs is proliferation. Therefore, 
smooth muscle hyperplasia is a significant finding in asthma, chronic bronchitis, and chronic 
obstructive pulmonary disease (COPD). In asthma, ASMCs become over-reactive and can 
constrict airway lumens in response to various stimuli (for example, pollen).  In emphysema and 
COPD, there is a noticeable loss of small airways, less than 2 mm in diameter, by an 
incompletely understood mechanisms [4]. In both conditions, affected individuals experience 
difficulty breathing, and lung function is compromised. In contrast to asthma, in patients with 
COPD there is thickening and subepitheial fibrosis of distal small caliber airways, with a 
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deposition of extracellular matrix proteins [4] that leads to an increase in airway wall rigidity and 
affect ASMC function.  
In general, smooth muscle cells are very responsive to changes in the physical properties 
of their marix. For example, “hardening” of the vascular walls in atherosclerosis is associated 
with increased proliferation in vascular smooth muscle cells through up-regulation of PDGFR 
signaling [5]. The change in mechanical stiffness of vessels can be quite significant in a diseased 
state: for example, the elastic modulus of the vascular wall rises from around 30 kPa in control to 
80 kPa in atherosclerotic vessels of a rabbit model of atherosclerosis. Nevertheless, there is 
paucity of information on mechanical stiffness of the lung itself, and less regarding its alteration 
during pathological processes. Measuring the rigidity of lung tissue is quite laborious, and 
available data are scarce. However, it is clear that mechanical properties of the lung are 
determined by the extracellular matrix rather than live cells [6], and that changes in lung stiffness 
are very localized, with a wide range in values [7].  Shear modulus of normal lung parenchyma 
has been found to be 0.5 kPa; however, pulmonary tissue is composed of many different 
constituents, with each likely having different mechanical properties [8]. Therefore, no 
information is available about the mechanical properties of small bronchi and bronchioles that 
comprise the niche for airways smooth muscle cells.  
In this study, we hypothesized that mechanical stiffness of the cell adhesion matrix would 
modulate growth and inflammation-activated proangiogenic growth factor secretion in ASMCs.   
To examine this hypothesis we cultured human AMSCs on collagen-conjugated polyacrylamide 
(CCP) hydrogels with varying mechanical stiffness.  Specifically, gel stiffness was tuned to 
reflect the ASMC niche in conditions of airway edema/emphysema, in normal bronchial mucosa 
and in pulmonary fibrosis (elastic moduli of 15, 27 and 93 kPa, respectively) [9-10].  Cell culture 
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media were supplemented by tumor necrosis factor or transformation growth factor-beta, in order 
to recapitulate inflammatory extracellular microenvironment.  Additionally, cellular adhesion 
morphology and β1-integrin expression were examined to elucidate a possible mechanism by 
which matrix rigidity modulates cellular secretory activities.  We believe that the results of this 
study will contribute to better understanding of the role of ASMCS in airway homeostasis and 
remodeling induced by chronic inflammatory lung diseases.   
 
Hydrogel M E (kPa) Q 
1 0.01 15 ± 1.1 43.2 ± 2.0 
2 0.03 26.9 ± 0.4 24.1 ± 0.8 
3 0.06 92.6 ± 5.9 16.0 ± 0.7 
M: Molar ratio of N,N′-methylenebis(acrylamide) to acrylamide; E: Elastic modulus, Q: Degree of swelling  
Table 3: Composition and properties of hydrogels. 
 
3.2 Materials and Methods 
3.2.01 Preparation of hydrogels 
For preparation of collagen-conjugated polyacrylamide gels with different elastic moduli, 
3 mg/ml bovine type I collagen solution (PureCol, Advanced Biomatrix) was first incubated with 
50 mg/ml poly(ethylene glycol) N-hydroxy succinimide ester (Acrylate PEG-NHS, Jenkem 
Technology) at a ratio of 10:1 at 4 ºC for two hours.  Then, collagen bound to acrylate PEG-NHS 
was mixed with stock solutions of 40% (w/w) acrylamide and 2% (w/w) N,N′-
methylenebis(acrylamide), and finally with 10 % (w/w) ammonium persulfate (Sigma) and 10 % 
(w/w) tetramethylethylenediamine (TEMED, Fluka).  The molar ratio between 2 % N,N′-
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methylenebis(acrylamide) and acrylamide was varied from 0.01 to 0.06 (Table 3).  The mixture 
was poured in a space between two glass plates separated by a 1 mm spacer.  After 10 minutes, 
the resulting gel disks with 1 cm-diameter were punched out using a puncher.  The gel disks 
were further incubated in phosphate buffered saline (PBS) at room temperature overnight before 
plating ASMCs on the gel.  PBS was exchanged three times a day.   
 
3.2.02 Analysis of hydrogel stiffness 
Mechanical stiffness of the collagen-conjugated polyacrylamide gels was evaluated by 
measuring the compressive elastic moduli of the gel.  After incubation in PBS over 24 hrs, gels 
were compressed at a rate 0.1 mm/min using a mechanical testing system (MTS Insight).  The 
compressive elastic modulus was calculated using the first 10% of strain (Table 2).  Three 
samples were measured per condition.  
 
3.2.03 Cell culture 
In all experiments, we used primary human airway smooth muscle cells derived from 
female patients at Mayo Clinic (Rochester, MN) as described [11]. Cells with passages between 
2 and 8 were cultured in DMEM/F12 (Mediatech, CellGro
R
) supplemented by 10 % fetal bovine 
serum (Invitrogen), 1:100 GlutaMAX
TM
 (Invitrogen), and penicillin and streptomycin 
(Invitrogen). The cells were seeded on hydrogel discs and incubated at 37 ºC and at 5% CO2.  
For the analysis of cell proliferation and VEGF secretion, the cells were seeded at a density 
10,000 cells/cm
2
. For all other experiments, we plated 1000 cells/cm
2
.  
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3.2.04 Staining for actin 
Cells were washed twice with pre-warmed neutral PBS. Then, samples were fixed in 
warm 4 % formaldehyde solution in PBS for 10 minutes and washed twice with PBS at room 
temperature. Next, gels with fixed cells were permeabilized by incubating in a solution of 0.1% 
Triton X-100 in PBS for 5 minutes. After blocking in 3% BSA solution, Alexa Fluor 488 
phalloidin (Invitrogen) was added as per manufacturer’s instruction. Nuclei were stained with 
4',6-diamidino-2-phenylindole (DAPI). Slides were mounted with Prolong Gold Antifade 
Reagent (Invitrogen). 
 
3.2.05 Immunocytochemical analysis 
   Cells were fixed in warm 4% neutral buffered formalin solution for 30 min, then 
incubated in 0.1% Triton-x (Sigma) solution for membrane permeabilization. Fixed samples 
were blocked in 3% bovine serum albumin solution in PBS and incubated overnight at 4 ºC with 
primary antibodies: mouse Anti-Integrin 1 antibody (Abcam), and rabbit polyclonal anti-
phospho-integrin linked kinase (ILK) antibody (EMD Millipore). The slides were washed three 
times with PBS and treated with secondary antibodies: Alexa Fluor 568 goat anti-mouse 
antibody (Invitrogen) and Alexa Fluor 488 donkey anti-rabbit antibody (Invitrogen). All 
antibodies were applied in dilution 1:1000. Images were prepared with a laser scanning confocal 
microscope (LSM 700, Zeiss). Specifically, β1-integrin was detected by exciting samples at 555 
nm and collecting emission ranging from 560 nm to 600 nm.  Integrin-linked kinase was imaged 
by exciting samples at 488 nm and collecting emission ranging from 488 nm to 550 nm.   
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3.2.06 Analysis of cell proliferation  
Cell proliferation rate was evaluated with (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay [12].  ASMCs were seeded on hydrogel disks at a 
density of 10,000 cells/ cm
2
. MTT assay was done at 12h and 72 h after cell plating. The results 
of the assay were based on reading the light absorbance at 570 nm on a microplate reader (Biotek 
Synergy HT). Experiments were repeated three times in triplicate.  
 
3.2.07 Intracellular [Ca
2
]i imaging  
Human ASMCs grown on hydrogels were incubated in 5 µM fura-2 AM (Invitrogen) for 
45 minutes at room temperature and fluorescence was visualized using a Nikon Eclipse TE2000-
U inverted microscope with 40x lens. Cells were perfused with Hank’s Balanced Salt Solution 
(HBSS) containing 2mM Ca
2+
 while being alternately excited
 
at 340 and 380 nm with a Lambda 
10-2 filter changer (Sutter
 
Instrument, Novato, CA).  Baseline fluorescence was briefly 
established and [Ca
2+
]i responses
 
to 10 μM histamine measured in 5-10 cells from software-
defined
 
regions of interest. Fluorescence emissions were collected separately
 
approximately 
every 2 seconds for each wavelength with a 510-nm barrier filter. Images were
 
acquired with a 
Photometric Cascade digital camera system (Roper Scientific, Tucson, AZ) and results were 
expressed using the ratio of the 340nm/380nm wavelengths.  
 
3.2.08 Human VEGF ELISA 
  VEGF secretion by ASMCs was measured with R&D Duo Set Human Elisa Kit 
according to manufacturer’s instruction. In brief, ASMCs were plated at 10,000 cells/cm2 on 
hydrogel discs, and hydrogels were placed into 12-well plates with 0.7 ml culture medium. 
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Samples of medium for ELISA were collected at 72 h after initiation of the experiment. For 
stimulation of VEGF secretion, transforming growth factor β1 (TGFβ1) or tumor necrosis factor 
α (TNFα) were added into the medium in concentration 10 ng/ml and 100ng/ml, respectively. 
Capture antibodies were adsorbed to the bottom of a 96-well plate overnight. After 3 washes 
with the wash buffer (0.05% Tween 20 in PBS), the wells were blocked with the diluent reagent 
(1% bovine serum albumin in PBS) and 100  μl of tested media was added to each well and 
incubated for 2 hours at room temperature. The VEGF present in the medium was detected by 
the detection antibody via streptavidin-horseradish peroxidase system reacting with the substrate 
solution. The reaction was stopped with a 2N solution of H2SO4. 
 
3.2.09 Morphometric analysis 
NIH ImageJ software was utilized for all morphometric analyses of ASMCs. Phase 
contrast images of proliferating cells were captured using an inverted microscope (DMI 4000B, 
Leica) equipped with a digital camera ORCA-ER (Hamamatsu Photonics).  
 
3.2.10 Statistical analysis 
At least, three repeats were done for each experimental group; and 50 cells or more were 
analyzed for each condition unless indicated otherwise.  Statistical significance was determined 
via one way ANOVA test, where p < 0.05. The data is presented with mean ± SD unless 
indicated otherwise.  
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Figure 13: Cell spreading and cytoskeletal architecture. Human airway smooth muscle cells were seeded on 
collagen – polyacrylamide conjugated gels with elastic moduli of 15, 27 or 93 kPa at a density of 1000 cells/cm3 and 
stained for actin microfilaments with Alexa Fluor 488 phalloidin (Invitrogen). We analyzed cell shape and 
distribution of actin filaments (A) and measured cell adhesion area (B), aspect ratio (the ratio of cell long axis to its 
short axis) (C), cell circumference (D). Nuclei stained with DAPI (blue). Brackets and * indicate statistically 
significant groups (p < 0.01). Approximately 100 cells were evaluated for each experimental condition. Bars and 
error bars represent the mean and standard deviation. Scale represents 20 micrometers. 
 
3.3 Results 
3.3.01 Preparation of collagen – conjugated polyacrylamide gels with controlled rigidity 
 Cell adherent polyacrylamide gels with controlled elastic moduli (E) were prepared by 
chemically conjugating bovine type I collagen in the same concentration to the hydrogel.  E of 
the gel was controlled by varying the molar ratio between N,N′-methylenebis(acrylamide) and 
acrylamide (Mc).  Specifically, increasing Mc from 0.01 to 0.03 and 0.06 led to an increase of E 
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from 15 to 27 and 93 kPa (Table 3).  The resulting elastic moduli were similar to the stiffness of 
normal bronchial mucosa and pathologically soft (edematous) and stiff (fibrotic) tissue [7, 10, 
13].  Introduction of -acryloyl--carboxy succinimidyl ester poly(ethylene glycol) and collagen 
molecules into the gel-forming mixture created the gel chemically conjugated with collagen 
through lysines of  collagen trihelix [10, 14].  As expected, cells exclusively adhered to the gel 
chemically coupled with collagen molecules.  No cells attached to the collagen-free hydrogel.   
 
3.3.02 Effects of Egel on cellular adhesion 
 We examined adhesion morphology of ASMCs adhered to gels with varying E. Within 3 
hours after seeding cells on the gel surfaces, more than 90 % of cells were attached to the gel, 
independent of E (not shown).  However, the cell adhesion morphology was dependent on E of 
the gel (Fig. 13A).  Specifically, the extent of cell spreading, quantified by cell adhesion area 
using NIH Image J software, was proportional to E of the gel, so that cells adhering to the gel 
with E of 93 kPa occupied 3.4 times larger area than cells adhered to the gel with E of 15 kPa 
(Fig. 13B).  ASMCs adhered to a softer gel were elongated, leading to linear decrease of an 
aspect ratio with increasing E of the gel (Fig. 13C).  The aspect ratio in cells adhered to the gel 
with E of 15 kPa was almost 4.2 times higher than in cells adhered to the gel with E of 93 kPa.  
Cell circumference was more than 1.2 times lower on the gel with E of 15 kPa, compared to the 
stiffer gels, whereas no significant difference was found between the gels with E of 27 and 93 
kPa (Fig. 13D).  
 Intracellular cytoskeletal organization was also dependent of E of the gel (Fig. 13A).  The 
cells adhered to the gels with E of 27 and 93 kPa exhibited fully stretched actin fibers, while 
those adhered to the gel with E of 15 kPa displayed limited numbers of short actin fibers.  
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Figure 14: ASMC morphology and [Ca
2+
]i release. Human airway smooth muscle cells were seeded on collagen – 
polyacrylamide conjugated gels with elastic moduli 15, 27 or 93 kPa. We evaluated the [Ca
2+
]i release on the gels 
with elastic moduli 27 and 93 kPa. 10 μM solution of histamine was used as an agonist to induce [Ca2+]i increases 
(A). Phase contrast images demonstrate SMC morphology and varying degrees of cell monolayer confluency on the 
gels with elastic moduli 15, 27 or 93 kPa at 72 hours post-seeding (B). Bars and error bars represent the mean and 
standard deviation. Scale represents 100 micrometers.  
 
3.3.03 Effects of Egel on intracellular calcium transport  
The release of intracellular calcium is directly related to the contractile function of SMCs 
that regulates the diameter of airways in the lung. Calcium [Ca
2
+]i activates a cascade of 
reactions that induce contractions in SMCs and lead to a decreased lumen in small and medium 
diameter bronchi [11]. Thus, the excitability and high levels of intracellular calcium ions are 
directly associated with the airway hyper-reactivity characteristic for asthma. Our results 
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indicated significant difference in [Ca
2
+]i levels in SMCs on the matrix with elastic moduli 27 
and 93 kPa. SMCs cultured on the substrate with E of 27 kPa released high amounts of [Ca
2
+]i 
as assessed by F340/F380 ratio (Fig. 14A). We were unable to collect results from cells on soft 
matrix (E = 15 kPa) because cells detached following the addition of histamine. 
 
Figure 15: ASMCs proliferation. Human airway smooth muscle cells were seeded on the collagen – 
polyacrylamide conjugated gels with elastic moduli 15, 27 or 93 kPa at a density 10,000 cells/cm
3
, and the change in 
the percentage of viable cells was calculated based on MTT assay performed at 3 h and 72 h time points (A). 
Interference contrast images demonstrate varying degrees of cell monolayer confluency on the gels with elastic 
moduli 15, 27 or 93 kPa following the addition of MTT reagent (B). Bars and error bars represent the mean and 
standard deviation. Scale represents 100 micrometers. 
 
 
3.3.04 Effects of Egel on cellular proliferation 
  Effects of Egel on cell proliferation was evaluated by examining an increase of the 
number of cells positively stained by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
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bromide (MTT) at 3 and 72 hours post-seeding (Fig. 15A and B). Only a small increase in cell 
numbers was observed on the gel with E of 27 kPa, whereas 37% increase in the numbers of 
viable cells was found on the gel with E of 93 kPa.  Thus, the cells adhered to the stiffest gel 
reached confluency in the end of the experiment (Fig. 14B and 15B).  In contrast, there was a 
significant decrease in the numbers of viable cells on the gel with Egel of 15 kPa. 
Figure 16: Matrix stiffness-dependent VEGF secretion. Human airway smooth muscle cells were seeded on the 
collagen – polyacrylamide conjugated gels with elastic moduli 15, 27 or 93 kPa at a density 10,000 cells/cm3. VEGF 
secretion was evaluated with a human VEGF ELISA kit 72 hours post-seeding. TGFβ1 or TNFα were added to 
stimulate VEGF secretion as indicated.    - The gel with an elastic modulus 15 kPa,   – The gel with an 
elastic modulus 27 kPa,   – The gel with an elastic modulus 93 kPa.  * - indicates statistically significant 
differences (p < 0.05). Bars and error bars represent the mean and standard deviation. 
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3.3.05 Matrix stiffness-dependent cellular VEGF secretion 
 We further studied whether Egel modulates cellular proangiogenic activity by examining 
cellular secretion of VEGF in the absence and presence of inflammatory cytokines.  In the 
absence of inflammatory cytokine, ASMCs on the gel with Egel of 15 kPa secreted 2.7 and 5.8 
times more VEGF than those plated on the gels with Egel of 27 and 93 kPa, respectively (Fig. 
16).    
Further exposure of ASMCs to inflammatory cytokines including TNFα and TGFβ1 for 
72 hours significantly elevated the amount of VEGF secreted by cells.  TGFβ1 was more 
effective to stimulate cellular VEGF secretion than TNFα (Fig. 16).  In presence of TNFα in the 
cell culture medium, cells adhered to a gel with Egel of 15 kPa secreted 2 and 1.7 times more 
VEGF than those adhered to the gels with Egel of 27 and 93 kPa, respectively.  In a similar 
manner, in the medium supplemented by TGFβ1, softer gels stimulated cells to secrete 3.3 and 
1.9 times more VEGF than the intermediate stiff and most rigid gel, respectively.  
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Figure 17: β1-Integrin expression and VEGF secretion. Human airway smooth muscle cells were seeded on  
collagen – polyacrylamide conjugated gels with elastic moduli 15, 27 or 93 kPa at a density 1000 cells/cm3. β1-
Integrin expression was detected by staining with anti - β1-integrin antibodies at 24 hours post-seeding. β1-integrin 
expression was quantified by the intensity of the fluorescent signal using ImageJ software (A and B) (β1-integrin 
expression was compared to the β1-integrin expression on the gel with E of 93 kPa, which was 100%). Plot (C) 
demonstrates positive correlation between expression of integrin β1 and the amount of secreted VEGF. The amount 
of β1-integrin expressed on a gel with E of 93 kPa is 100%.  *- statistically significant groups (p < 0.05). Bars and 
error bars represent the mean and standard deviation. 
 
 
3.3.06 Effects of Egel on integrin β1 expression 
  Here, we tested integrin β1expression in ASMCs adhering to substrates with elastic 
moduli 15, 27 and 93 kPa. Integrin β1 is a major integrin that facilitates attachment to collagen I 
substrate in fibroblasts and smooth muscles cells [15-18]. It is often responsible for cell 
attachment necessary for cell migration, but unlike integrin β3, integrin β1 is particularly 
exploited for adhesion to uninjured tissue in the form of integrins α1β1 and α2β1 [18].  It was 
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reported that secretion of several cytokines by ASMCs is regulated by integrin β1 – ligand 
binding, particularly to collagen I [15].   
Integrin expression level was assessed with images of cells immunostained after 24 hours 
of cell culture using NIH Image J software.  According to images, integrin β1 in the cell adhered 
to gel with Egel of 15 kPa was mostly localized in the moving “front edge” of the cellular 
membrane (Fig. 17A).  In addition, the integrin expression level was inversely proportional to E 
of the gel (Egel).  Specifically, ASMCs adhered to the gel with Egel of 15 kPa expressed 2.4 and 
1.7 times more integrin β1 than those adhered to the gel with Egel of 27 and 93 kPa, respectively 
(Fig. 17B).  Therefore, the cellular VEGF secretion level was linearly proportional to the cellular 
β1 integrin expression level (Fig. 17C). Furthermore, we examined effects of Egel on the cellular 
expression of the phosphorylated integrin – linked kinase (ILK) that is involved in signaling via 
β-integrins (Figure 18). The expression level of phosphorylated ILK, analyzed by the intensity of 
staining with anti-ILK antibodies, was inversely related to Egel (Fig. 18A & C) Specifically, the 
expression level was decreased by a factor of 1.8 when increasing Egel from 15 to 93 kPa.  Again, 
the cellular VEGF secretion level was linearly proportional to the cellular ILK expression level 
(Fig. 18B).   
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Figure 18. Phospho-ILK expression on substrates with varying stiffness. Human airway smooth muscle cells 
were seeded at a density 1000 cells/cm
3
on collagen – polyacrylamide conjugated gels with elastic moduli of 15, 27 
or 93 kPa. Phosphorylated ILK was detected with fluorescent antibodies, and its expression was quantified by the 
intensity of the fluorescent signal using ImageJ software (A and B) The expression of phospho-ILK on a gel with E 
of 93 kPa is 100%. The difference is statistically significant between all groups (p < 0.01). Positive correlation is 
present between the amounts of phospho-ILK expression and released VEGF (C). Bars and error bars represent the 
mean and standard deviation. Scale represents 50 micrometers.  
 
 
3.4 Discussion 
Airways smooth muscle cells fulfill a wide variety of functions in the lung, including the 
regulation of airway diameter and the secretion of growth factors, such as VEGF [19]. ASMCs 
occupy a narrow compartment between respiratory epithelium and the scarce fibrous connective 
tissue of adventitia, with an equilibrium maintained between various parts of this niche in normal 
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tissue. As we demonstrated in this study, mechanical properties of ASMC matrix niche are 
crucial for the maintenance of their normal and appropriate behavior. For example, the changes 
in tissue stiffness that accompany such lung diseases as asthma, pulmonary fibrosis and chronic 
bronchitis [9] and lead to disruption of the niche and airway restructuring. This often results in a 
change of the ratio between airway tissue components, particularly with regards to the amount of 
the vascular component and fibrous connective tissue [4, 20]. The analysis of how the ASMC 
physical niche environment impacts the changes is compounded by ASMC own ability to change 
the stiffness of airways [21]. 
Similar to vascular smooth muscle cells [5], in our study a stiff substrate caused ASMCs 
to form a large cell adhesion area and establish prominent stress fibers (Figure 13A & B). In 
contrast to vascular smooth muscle cells however, the ASMCs on the soft gel either became 
rounded or extremely elongated, nevertheless they remained adhered to the matrix (Figure 13A 
and C) [5], with cell numbers decreasing only by 33% (Figure 15A) over a three day period. The 
intermediate substrate, with an elastic modulus 27 kPa, maintained ASMC population in a stable 
state without significant change in cell numbers over the same culture period (Figure 15A and 
B). Therefore, we suggest that the mechanical stiffness (elastic modulus) of the ASMC natural 
environment must be close to 27 kPa. Under such conditions, there will be no pathological 
smooth muscle hyperplasia or hypoplasia induced by a sub-optimal substrate stiffness. Similar to 
results seen using vascular smooth muscle cells [5], our results demonstrate that stiff substrates 
with an elastic modulus 93 kPa cause a 37% increase in ASMCs population size (Figure 15A and 
B) indicating that substrate rigidity itself can be an important player in a pro-fibrotic response.  
 Interestingly, the mechanical responsiveness of smooth muscle cells was altered in cells 
attached to substrates of varying stiffness. This was evidenced by the calcium ion release assay 
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(Figure 14A). The cells on the intermediate gels exhibited higher levels of calcium signaling than 
the cells on the stiff matrix. Lower responsiveness of airway SMCs to the stimulant (histamine) 
on the stiff substrate can be an evidence of a compensatory role that subepithelial fibrosis 
followed by airway stiffening may play during the pathogenesis of asthma. The stiffening of the 
basement membrane to which ASMCs adhere reduces ASMC ability to overreact to incoming 
stimuli and completely constrict the airway lumens. Our results demonstrate that ASMCs are 
more responsive to the action of excitatory agents, for example pollen, on softer matrix. This 
would be followed by a dramatic decrease in lumen diameter in asthmatic patients.  The cell 
reaction on the intermediate substrate is most likely an indication of wider physiological leeway 
for cellular response on the matrices with physiological (intermediate) stiffness. When the 
subepithelial fibrosis sets in, changed physical matrix properties would reduce ASMC control of 
airway diameter by interfering with cell’s responsiveness to excitatory signals.  
 Integrin signaling is crucial for ASMC adhesion and proliferation; with particularly 
integrin β1 having the greatest effect on smooth muscle proliferation [17]. The deposition of 
ECM components is often stimulatory for integrin signaling [15]. However, the accumulation of 
collagen I, a well known ligand for α1β1 and α2β1 integrins [22], in asthma and chronic 
bronchitis is also compounded by a simultaneous increase in mechanical stiffness of airways 
[17]. Thus, both the over-abundance of integrin ligands and the increase in stiffness distort 
normal receptor – ligand relationship in a diseased lung. We demonstrate for the first time that 
integrin β1 expression in ASMCs is increased on soft (elastic modulus approximately 15 kPa) 
collagen I – conjugated matrices, with expression concentrating around the leading edge of a 
smooth muscle cell (Figure 17A & B).   Therefore, integrin β1 expression in ASMCs resembles 
that of fibroblasts increasing their integrin β1 expression, particularly α2β1, when cultured on 
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soft collagen matrices [16]. In general, integrins α2β1 and α1β1 are particularly required for a 
cell adhesion and migration to a stable matrix [16]. Both integrins are required for in vitro 
adhesion to the collagen and for collagen gel contraction [23]. Marked concentration of integrin 
β1 along the leading edge on softer matrices could be explained by a higher level of cell motility 
on such substrates (Fig. 17A). This is corroborated by the fact that newly formed integrin 
connections are confined to the leading edge creating a gradient [24]. Moreover, integrin 
activation, turnover and recycling occur at a faster rate on softer matrix [25]; and this could be 
responsible for the increased expression of integrin β1 in SMCs.  
It is worth noting that integrin β1 is not only involved in a cell adhesion, but it also 
modulates secretory function in adhering cells, including ASMCs [15].  Airway smooth muscle 
cells are an important source of cytokines and growth factors in the lung, and their release is 
controlled through the interaction with the matrix that is often mediated by integrin β1 [15].  In 
this study, we show that the amount of VEGF secretion is positively correlated with integrin β1 
expression (Figure 17C). Thus, the integrin β1 may be involved in VEGF signaling in ASMCs 
through its ability to sense the rigidity of collagen I – conjugated matrix. The amount of secreted 
VEGF was dependent on the mechanical stiffness of the matrix, with higher VEGF levels 
produced on softer matrix (Figure 14), with all differences being statistically significant.  
Vascular endothelial growth factor is produced by many cell types, including ASMCs. It 
is very abundant in lung tissue [26].  However unlike other cell types, ASMCs constitutively 
secrete VEGF and are an important source of this growth factor in the airways [2]. VEGF is 
important for the maintenance of alveolar capillary bed, and the lack of VEGF has been 
implicated in capillary network degeneration in pulmonary emphysema [26-27]. In contrast to 
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that, local over-abundance of VEGF is involved in increased vascularity of airways in asthma 
and chronic bronchitis and the associated remodeling [27]. 
 The connection between the integrins and VEGF expression has not been adequately 
elucidated, but recently a missing link between two components of the integrin – VEGF 
signaling cascade was found. This is integrin – linked kinase (ILK) - an upstream regulator of 
PKB/Akt pathway. ILK binds the intracytoplasmic tails of β-integrins, and is essential for HIF-
1α and VEGF expression in at least one cell type – prostate cancer cells [28]. An increase in ILK 
activity was reported to be positively dependent on β1 integrin - type I collagen interaction in 
some studies [29]. We tested the expression of phosphorylated ILK (phospho – ILK) on 
substrates with varying stiffness and found that phospho-ILK expression was stiffness – 
dependent, with highest levels expressed on softer matrices (Figure 18). This is in line with our 
observations on stiffness-dependent VEGF release which also increased on softer gels as was 
mentioned above (Figure 16). Thus, VEGF secretion by ASMCs is ECM stiffness – dependent 
and likely to occur via sensing by integrin β1 and through an ILK – mediated mechanism. 
Positive relationship between ILK and VEGF expression was also described before in prostate 
cancer cells [28] as was mentioned above. However, the mode of interaction between integrins, 
and particularly integrin β1, and ILK is less clear and some conflicting data have been published 
[29-30]. 
 
3.5 Conclusion 
 Overall, airway smooth muscle cells are very responsive to the mechanical stimuli 
presented by the matrix. They spread with a larger adhesion area on more rigid surfaces, which 
also induces more rapid proliferation. Cell proliferation and cell attrition was balanced out on the 
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matrix with an elastic moduli 27 kPa. Therefore, it is likely that this stiffness is more 
physiologically relevant for this particular type of mesenchymal cells. Interestingly, integrin β1 
expression was highest on the softest gel and predominantly confined to the leading edge of a 
migrating MSC. Triggering of calcium release by histamine induced dampened response on 
stiffer gels, indicating that airway stiffening due to subepithelial fibrosis in asthma could be a 
compensatory mechanism to depress the responsiveness of SMC to irritants.  Overall, this work 
will further contribute to understanding of airway smooth muscle physiology.  
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Chapter 4: Angiogenic Patch for Stem Cell Delivery into Ischemic Hind Limb 
4.1 Introduction 
Peripheral arterial disease (PAD) usually develops as a sequel to diabetes mellitus and 
atherosclerosis and is accompanied by a loss of normal blood perfusion in the lower limbs [1]. In 
this condition, major arteries become occluded by atherosclerotic plaques and thrombi, 
significantly reducing the volume of oxygenated blood flowing through the tissues including 
muscles and skin. Limb ischemia in PAD is a slow process that over the years can lead to 
complete loss of perfusion, development of gangrene, and ultimately may result in the loss of the 
affected limb [2]. In the United States, more than 5 million people were affected with PAD in 
1999 – 2000 [2]. The change of lifestyle was proposed for amelioration of observed ill effects of 
PAD that includes smoking cessation and regular exercises, with management of diabetes, high 
blood pressure and cholesterol. In more advanced cases, patients require angioplasty and plaque 
excision, bypass grafting or amputation. However, an active search for modern and effective 
ways to treat critical limb ischemia is ongoing, and there are certain successes achieved in human 
patients via gene therapy [3-4].  Recently, a lot of efforts have been focused on direct local 
angiogenic growth factor delivery and stem cell-based treatments [5-7].     For example, the 
injection of VEGF together with fibrin meshwork has been shown to improve revascularization 
at the ischemic site in human patients [8]. Although there are a great variety of different 
experimental approaches to treat advanced PAD, few of them have been implemented clinically 
on a wide scale.  
A mouse model of hind limb ischemia has been recently established allowing researchers 
to investigate therapies that lead to amelioration of clinical signs and pathological changes 
during limb ischemia in vivo [9-10]. In this model, femoral artery running on the inner surface of 
a thigh along the femoral bone is ligated and incised to prevent blood flow to the lower limb 
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[11].  Local hypoxia developing after the dissection of the femoral artery creates conditions for 
redistribution of blood into the smaller collateral vessels and for activated focal angiogenesis. 
We used this model for implantation of cell-laden implants to detect an increase in local 
angiogenesis/ arteriogenesis.  
This study presents a design of alginate-based angiogenic patch laden with bone marrow 
derived human mesenchymal stem cells (MSCs) for a long term delivery of angiogenic factors. 
Human bone marrow-derived MSCs are produced from the bone marrow of adult individuals. 
The cells can be maintained in undifferentiated state or be differentiated into one of several 
lineages: bone, cartilage, tendon, fat, muscle, and marrow stroma [12-14]. One of the great 
advantages of MSCs is their immunomodulatory action that facilitates their use for autologous as 
well as allogeneic transplantations [13, 15].  Recently, human mesenchymal stem cells have been 
shown to secrete significant amounts of angiogenic factors, such as vascular endothelial growth 
factor (VEGF) and basic fibroblast growth factor (βFGF) [16-17]. Moreover, biologically active 
molecules, such as interferon γ (IFNγ), can be used to augment the release of pro-angiogenic 
factors from MSCs [18-19]. We hypothesized that aligned pores within biopatch constructs 
would provide more “living space” for stem cells, accommodate for cell proliferation and allow 
for a longer survival of stem cells within the channels. This would permit the cells to produce 
greater amounts of VEGF over time, thereby activating the local angiogenesis [20].  
 This hypothesis was tested using alginate hydrogels. Alginate was functionalized by 
conjugation of RGD peptides that were intended to provide adhesion sites for populating stem 
cells. Aligned pores (microchannels) in the disks of lyophilized hydrogels were produced by a 
method of controlled unidirectional freezing. Additionally, to activate the secretion of VEGF 
from MSCs, microparticles encapsulating IFNγ were incorporated into the gel biopatches. After 
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dry-freezing, human bone marrow-derived MSCs were incorporated into the microchannels. 
Then, the hydrogel disks laden with stem cells were coated with freshly polymerized alginate gel 
for protection of incorporated cells from immediate immune-mediated destruction by an 
immune-competent host. Further, the cell-laden gel disks were tested for VEGF release in vitro 
and imaged via confocal microscopy. And finally, the constructs were studied as implants in a 
mouse model of hind limb ischemia, in order to demonstrate that MSCs-laden hydrogel patches 
with anisotropically aligned pores can significantly improve blood perfusion and 
revascularization in vivo within an ischemic limb.  
 
4.2 Methods and Materials 
4.2.01 RGD peptide conjugation to alginate 
 Alginate (Mw ~ 250,000 g/mol, FMC Biopolymer) was dissolved in the 0.1 M 2-(N-
morpholino)ethanesulfonic acid solution with pH6.5 (MES buffer) at a concentration of 1 % 
(w/w).  After that, sulfonated N-hydroxysuccimide (Sulfo-NHS, Thermo Scientific), 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide (EDC, Thermo Scientific) and the oligopeptide with a 
seuqnence GGGGRGDSP (RGD peptide) (Mimotopes Pty Ltd.) were sequentially added to the 
alginate solution, and stirred for 24 hrs in molar ratio alginate : Sulfo-NHS : EDC : RGD peptide 
= 1 : 3 : 2 : 2. The alginate solution was dialyzed against deionized water for 48 hours. The water 
was replaced three times a day.  The alginate coupled with RGD peptides (RGD-alginate) was 
collected via lyophilization. 
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4.2.02 Fabrication of alginate hydrogels 
Alginate (Mw ~ 250,000 g/mol, FMC Biopolymer) or RGD-alginate sterilized via 
filtration through a 0.22 μm filter was dissolved in MES buffer (0.1 M 2-(N-
morpholino)ethanesulfonic acid (MES, pH 6.5) at a concentration of 2% (w/w).  The alginate 
solution was mixed with 1-hydroxybenzotriazole (Hobt, Fluka), EDC, and adipic acid 
dihydrazide (AAD, Sigma-Aldrich) were sequentially added to the alginate solution, and the pH 
was adjusted to 6.0. The molar ratio of EDC:Sulfo-NHS:AAD was kept constant at 1.0:1.0:0.2.  
The molar ratio between AAD and uronic acid of alginate was also kept constant at 0.05:1. 
Subsequently, the pre-gelled mixture was poured into the space between two glass plates 
separated by a 1 mm spacer.  Ten minutes later hydrogel disks with diameter 5 mm were 
punched out with a puncher, and incubated in DI water at room temperature for 12 hrs.  Then, 
each gel disk was placed on a copper plate with thickness of 0.5 mm that was in contact with 
liquid nitrogen bath for 5 minutes. Polystyrene foam was used to insulate samples from the sides. 
The volumes of each hydrogel and the liquid nitrogen were kept constant to obtain reproducible 
results.  To prepare hydrogels with an elastic moduli (E) of 10 kPa and 40 kPa, the molar ratio 
between AAD and uronic acid was maintained at 0.05:1 and 0.2:1, respectively.    Frozen 
samples were freeze-dried and were stored in dried state until use at minus 20 C
o
.   For control 
experiments, hydrogel disks were directly dropped into the liquid nitrogen bath, in order to 
introduce randomly oriented micropores into the gel.  
 
4.2.03 Encapsulation of IFN- γ in alginate hydrogel 
 Poly(lactic-co-glycolic) acid (PLGA) microparticles (with a lactide : glycolide ratio of 
50:50, Mw = 6,000-10,000 g/mol, DURECT Co.) encapsulating Interferon-gamma (IFNγ, R&D 
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Systems) were prepared by water-in-water (W1/O/W2) double emulsification method. In brief, 
IFNγ (10 μg/mL) was dissolved in 50 μL PBS, water phase 1 (W1); and PLGA (20 wt%) was 
dissolved in dichloromethane, oil phase (O).  0.1 wt% aqueous poly(vinyl alcohol) (PVA) 
solution was used as the water phase 2 (W2). The primary emulsion was obtained by mixing 
IFNγ containing W1 with the oil phase, followed by sonication for 20 seconds. Then, the mixture 
was transferred into W2 and vortexed for 30 seconds to form the W1/O/W2 double emulsion.  
Finally, the resulting emulsion was poured into 0.1 wt% aqueous PVA solution and stirred for 4 
hours. The PLGA microparticles were dried through lyophilization. The dried PLGA 
microparticles encapsulating IFNγ were dispersed in the pre-gel solution, and the alginate gel 
with PLGA microparticles was fabricated by following the same procedure as described above.  
To produce gel discs, the alginate gel incorporating PLGA microparticles was placed on top of 
the copper plate, followed by the sequential, unidirectional freezing and lyophilization.   
 
4.2.04 Cell encapsulation into gel disks 
In all experiments we used human bone marrow-derived mesenchymal stem cells 
(MSCs), which had been derived from the bone marrow of human donors by Lonza 
Biotechnology Company. Cells were maintained in DMEM supplemented with 10% fetal bovine 
serum (FBS, Invitrogen), 1:100 GlutaMAX
TM
 (Invitrogen), and penicillin-streptomycin 
(Invitrogen). Weekly the cells were trypsinized and replated into new flasks at a ratio 1:3. For 
seeding into the gels, MSCs were dissociated from the plastic by incubating them in a 0.05% 
trypsin solution (Mediatech) for 10 min, and washing them in fresh DMEM supplemented with 
10 % FBS. A single cell suspension was prepared, and 300,000 cells were seeded in a volume of 
20 μl onto each gel. Most of the cell suspension was incorporated into the gel by capillary 
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suction. The gels laden with MSCs were coated with the low MW alginate solution (4 wt%). 
Then, drops of 0.1 M CaCl2 solution (100 μl) were added onto the gels for induction of 
polymerization of the alginate coating. 
 
4.2.05 Human VEGF ELISA 
  VEGF secretion by MSCs was measured with R&D Duo Set Human Elisa Kit according 
to manufacturer’s instruction. In brief, ASMCs were plated at 10,000 cells/cm2 on hydrogel 
discs, and hydrogels were placed into 12-well plates with 0.7 ml culture medium. Samples of 
medium for ELISA were collected after 2, 7 and 14 days after initiation of the experiment if not 
indicated otherwise. Capture antibodies were adsorbed to the bottom of a 96-well plate 
overnight. After 3 washes with the wash buffer (0.05% Tween 20 in PBS), the wells were 
blocked with the diluent reagent (1% bovine serum albumin in PBS) and 100  μl of tested media 
was added to each well and incubated for 2 hours at room temperature. The VEGF present in the 
medium was detected with the detection antibodies using streptavidin-horseradish peroxidase 
system. The reaction was stopped with a 2N solution of H2SO4. 
 
4.2.06 Surgical procedure 
All animal experiments were conducted in accordance with the protocol approved by the 
Institutional Animal Care and Use Committee. We used 8-12 week old C57BL/6 mice for all 
procedures. The animals were anesthetized with xylazine (10 mg/kg) and ketamine (100 mg/kg) 
cocktail via intra-peritoneal injection.  After surgical field was prepared, a one centimeter long 
skin incision was made on the inner thigh surface along the femoral bone. Next, the femoral 
artery was isolated from the overlying fascia and ligated proximally and distally with 5-0 Ethilon 
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sutures (Johnson & Johnson, NJ), to stop the blood flow to the lower left limb. The artery was 
cut between the ligatures and a gel disk was placed over the dissected vessel. Finally, two simple 
interrupted stitches were placed on the skin to close the surgical wound. Four mice were included 
into each experimental and control group. 
 
4.2.07 Laser Doppler perfusion imaging 
Perfusion recovery was assessed with Laser Doppler perfusion imager Periscan PIM3 
(Perimed AB, Sweden). For this, mice were briefly anesthetized with Isoflurane, and placed on a 
dark heated pad. The hairless palmar surfaces of hind limbs were scanned to detect a change in 
blood flow on the following time points after the surgery: 0 h, 24 h, 72 h, and weeks 1, 2, 3, 4 
and 5. The recovery of blood perfusion was normalized over the amount of blood flow in the 
intact right limb.  
 
4.2.08 Histopathology 
The mice were euthanized with carbon dioxide and necropsied. Tissues were fixed in 
10% neutral buffered formalin (NBF) for 24 h. After removal of bones, the limbs were sectioned 
and embedded in paraffin. Tissue blocks were sectioned using a Leica RM 2255 microtome and 
5 micron thick sections were prepared and stained with hematoxylin and eosin (H&E).  
 
4.2.09 Immunohistochemistry 
To assess the numbers of blood vessels in tissue sections we applied antibodies to smooth 
muscle actin, which detect larger diameter blood vessels with a tunica media. Using this 
technique we labeled arteries and veins, including smaller size arterioles and venules. Antigen 
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retrieval was performed in Tris-EDTA buffer at pH 9.0 using the vegetable steamer. The sections 
were incubated overnight at 4
0
C with a rabbit polyclonal anti-alpha smooth muscle actin 
antibody (Abcam) at a dilution 1:500. Internal peroxidase was blocked with 0.6% hydrogen 
peroxide solution. Horseradish peroxidase (HRP)-conjugated donkey polyclonal secondary 
antibody to rabbit IgG in dilution 1:1000 (Abcam) was applied at room temperature for one hour. 
As a chromogen we used 3,3'-diaminobenzidine (DAB) solution (Sigma). After counterstaining 
with hematoxylin, slides were mounted with Permount® mounting medium (Fisher Scientific).  
The stained slides were photographed with a NanoZoomer Slider Scanner/ Digital Pathology 
System (Hamamatsu). Revascularization was assessed by determining the density of blood 
vessels in the muscle tissue of the hind limb. Specifically, we measured the vessel density 
(numbers of vessels per 1 mm
2
) and vessel area (total area of all vessels per 1 mm
2
) in the calf 
and thigh muscles. For detection of MSCs in mouse tissues, we used rabbit polyclonal  
anti-2β microglobulin antibody (Αbcam) in dilution 1:100.  
 
4.2.10 Morphometric and statistical analysis 
All morphometric analysis was performed using the NDP view software (Hamamatsu Photonics, 
Japan). Each animal experimental group contained four animals. Statistical significance was 
determined via Student’s t test, where p < 0.05. The data is presented with mean ± SD.  
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Figure 19: Schematic describing preparation of gels with aligned pores. The gels were produced by a method of 
unidirectional freezing. During the procedure alginate gels insulated from the sides were placed with their bottoms 
on a copper plate over a vessel with liquid nitrogen. The slow crystallization of water molded aligned channels in 
vertical direction and compressed alginate scaffold with admixed IFNγ-PLGA microparticles to the sides of the 
pores (A). Resulting gels contained honeycomb-like vertically aligned micropores (microchannels) as the scanning 
electron microscopy (SEM) (the left microphotograph) and the light microscopy image (the microphotograph on the 
right) in (C) demonstrate. For comparison, a light microscopy image (lower panel on the right) demonstrating 
microporous structure of a gel with random pores (The scheme and the SEM image were produced by Dr Min 
Kyung Lee). 
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Figure 20: VEGF release by human MSCs cultured on alginate gels with varying mechanical stiffness. 10,000 
cells/cm
2 
were placed on the alginate gels with elastic moduli of 10 and 40 kPa or on glass slides with elastic 
modulus of 1 GPa. The amount of released VEGF was evaluated in culture media using R&D Duo Set Human Elisa 
Kit after one week in culture. 
 
4.3 Results 
4.3.01 Gels with anysotropically aligned pores  
We developed a directional freezing technique to create a unidirectionally 
microchannelled hydrogel-based micropatch. Additionally, the microchannels of the hydrogel 
were further modified to present poly(lactide-co-glycolic acid) (PLGA) microparticles 
encapsulated with interferon γ. The alginate solution was mixed with dispersed PLGA 
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microparticles and cross-linked with AAD to form a gel. The PLGA microparticles were 
randomly distributed in the gel without any directional organization (Fig. 19).  
 
Figure 21: Cell distribution within the gels and VEGF secretion profile. Human mesenchymal stem cells (MSCs) 
were seeded onto the gel disks and stained with phalloidin (green) and DAPI (blue) for visualization of cytoskeleton 
by confocal microscopy (A).  Gel disks, with incorporated human mesenchymal stem cells, were cultured in vitro 
for 2 weeks, and the medium was collected and analyzed with VEGF ELISA (B).  
 
4.3.02 MSC distribution in the gels 
 Confocal images of gels with adhered MSCs were made to address the adhesion and 
distribution of cells within the micropores (Figure 21A). MSCs formed large round aggregates of 
cells in the gel with non-aligned randomly distributed pores. In contrast, MSCs adhered in long 
parallel cords of cells to the inner surface of the gels with aligned pores (Figure 21A). Thus, the 
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gels with aligned pores provided adhesive surface for cells that were able to spread and likely 
migrate within the pores.  
 
4.3.03 VEGF release from gels in vitro 
 We measured the cumulative release of VEGF from implants seeded with human MSCs 
in vitro using ELISA. First, the secretion of VEGF was tested in the gels with stiffness of 10 and 
40 kPa and on glass slides with E of 1 GPa (Fig. 20). The amount of secreted VEGF was 1.2-fold 
and 2.3-fold higher on the gel with E of 10 kPa compared to the gel with E of 40 kPa and when 
grown on a glass slide with E of approximately 1 GPa (Fig. 20). Next, we used the gels with E of 
10 kPa for all further experiments. The best results were achieved using gels with incorporated 
MSCs, aligned pores and IFNγ microparticles (Fig 21B). They induced a 17% and 25% increase 
in total VEGF secretion by incorporated cells compared to the gels with non-aligned pores and 
the gels with aligned pores and no IFNγ, respectively (Fig. 21B). The general scheme of 
anticipated effects following the implantation of gels in vivo is depicted in Fig. 22. 
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Figure 22: Scheme describing proposed effects of a MSC-laden gel with aligned microchannels and incorporated 
VEGF-PLGA microparticles. PLGA microparticles degrade over a two week period and release interferon γ, which 
induces VEGF secretion from the MSCs. VEGF diffuses into the surrounding tissues and activates local 
angiogenesis.  
 
4.3.04 Perfusion recovery 
Following the prescribed surgical procedure, the blood perfusion in the hind limb was 
reduced by approximately 85-95% (Figure 23A). Remaining blood flow was in the range 
between 7 and 12 %. The application of cell-laden patches with aligned pores led to a significant 
increase in perfusion at the end of week 5 compared to the cell-free control (Figure 23A and B). 
The improvement was 2- and 1.5-fold when such gels, with interferon γ and without it, 
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respectively, were implanted. There was no significant difference between the gels with aligned 
microchannels when interferon γ was included or excluded from the gel composition.  
The cell-laden gels with random pores also induced improvement in blood perfusion over 
the time of observation; however, it was not statistically significant. The images in Figure 23B 
reflect gradual improvement in all treatment groups.  
 
Figure 23: Blood perfusion recovery following the implantation of gels. During the surgical procedure, femoral 
artery of the left hind limb was cut precluding blood flow to the limb. The perfusion recovery was measured with 
Laser Doppler perfusion imager (LDPI) and normalized by the perfusion in the right limb (A). Analysis was 
performed on images taken with the LDPI (B). Error bars indicate standard deviation. The bracket indicates 
statistical significant groups (p < 0.05).  
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4.3.05 Assessment of revascularization 
 Revascularization was assessed by determining the density of blood vessels in the muscle 
tissue of the hind limb. Specifically, we measured vessel density and vessel area in the calf 
muscles and muscles of the thigh. As was expected, the combination of the surgical procedure 
followed by a gel implantation induced a significant increase in vessel density and vessel area 
compared to control non-operated limb (Fig. 24).  
The gels with aligned pores promoted highest rates of revascularization based on image 
analysis. Interestingly, there was an increase in vessel density when gels with aligned pores were 
implanted regardless of interferon γ presence. Such gels induced an increase in the vessel density 
and vessel area more than two-fold compared to the cell-free gels with aligned micropores 
(Figure 24B and C). The cell-laden gels with non-aligned random pores occupy intermediate 
position in their effectiveness to promote revascularization between cell-free and cell-laden 
aligned gels (Figure 24B and C). The level of revascularization as judged by the vessel density 
and vessel area was very similar between cell-laden gels with aligned microchannels regardless 
of interferon γ presence (Figure 24B and C). In contrast, vessel density after implantation of cell-
laden gels with aligned pores was 2, 2.5 and 3.5 times higher compared to the groups with 
random pores, cell-free gels or in an intact limb (control), respectively. Similarly, the vessel area 
was approximately 2.5 times greater following the implantation of cell-laden gels with aligned 
pores with/without interferon compared to cell-free gels or cell-laden gels with random pores.  
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Figure 24: Assessment of re-vascularization. Calf and thigh muscles were fixed in 10% formalin, embedded in 
paraffin and sectioned. Sections were stained with antibodies against smooth muscle actin.  We measured the 
density of vessels and vessel area on the images produced by Nanozoomer digital pathology system. Error bars 
represent standard deviation. Brackets and * indicate statistically significant differences (p < 0.05). Bar represents 1 
mm. 
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Figure 25: Implant histopathology. Calf and thigh muscles were fixed in 10% formalin, embedded in paraffin and 
sectioned. Sections were stained with H&E. Images in the second row represent magnified views of images in the 
first row. All implants exhibit the presence of host cells and deposition of collagen (arrows) within microchannels 
and micropores. Variable numbers of macrophages are also present (arrowheads). A) Cell-free control implant with 
aligned microchannels incorporating IFNγ. B) Cell-laden implant with random micropores incorporating IFNγ. C) 
Cell-laden implant with aligned microchannels incorporating IFNγ. D) Cell-laden implant with aligned 
microchannels lacking IFNγ. 
 
4.3.06 Implant histopathology 
In all conditions, alginate implants were detectable 5 weeks after the surgery. In most 
cases, the implants were surrounded by a fine fibrous capsule. Adjacent areas were infiltrated by 
small numbers of macrophages, lymphocytes and fewer plasma cells. Macrophages often 
contained globules of amphophilic foreign material in the cytoplasm (presumably, degraded 
alginate).  
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Interestingly, the linearity of aligned pores was preserved in the implants even after fifth 
week (Figure 25A, C, D and insets). Interestingly, cell-free gels were significantly compressed, 
contained almost no free spaces within implants and were populated by large numbers of host 
cells (Figure 25A). In contrast, cell-laden gels in all three groups demonstrated large free zones 
within implants, filled with minimal numbers of migrated host cells (Figure 22B, C and D).  
 
Figure 26: Neutrophil accumulation near the interferon γ-free implants. (A) A graph demonstrating the 
percentage of implants with IFNγ and without IFNγ, which were accompanied by neutrophilic exudates. The 
numbers over graph bars indicate the implants infiltrated by neutrophils/ total number of implants examined. (B) A 
low power view of an implant with the marked neutrophilic response. (C) Magnified view of the inset in (B). The 
arrow indicates neutrophils, the arrowhead points at a macrophage.  
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Moderate to extensive areas infiltrated by large numbers of neutrophils were detected in 3 
out of 4 interferon γ-free gels. In contrast, only one out of 12 gels with encapsulated interferon γ 
contained similar accumulations of neutrophils in or near the implant (Fig 26).  
Further we investigated the survival of human MSCs in the implants using antibodies 
against a very species-specific cell surface marker β2-microglobulin that belongs to the major 
histocompatibility type 1 complex and allows detection of human cells in animal tissues [21]. 
BM-MSCs formed compact islands of small and slightly fusiform cells within the implants 
carrying no IFN γ (Fig. 27). No live MSCs were detected in the implants laden with PLGA-IFNγ 
microparticles.  
 
4.4 Discussion  
The results of this study demonstrate that the implantation of alginate based implants 
laden with human mesenchymal stem cells can accelerate revascularization in an ischemic tissue. 
Specifically, the combination of proper implant geometry with aligned pores and encapsulated 
MSC significantly improved blood perfusion recovery in an ischemic limb. In addition, the 
presence of anisothropic pores was more effective in blood flow recovery when MSCs were co-
implanted than incorporation of interferon γ.  
The method of directional freezing allowed us producing alginate-based implants with 
unidirectionally aligned pores that made the gel more penetrable for growth factors, cytokines 
and oxygen and other small molecules. Higher diffusion rates transform into better survival of 
encapsulated cells, because of high availability of nutrients and oxygen. The outward migration 
of cells from the implant was inhibited by a thin alginate cap that also protected incorporated 
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Figure 27: Bone marrow-derived MSCs (BM-MSCs) within an implant with aligned microchannels and 
without IFN γ. The photographs were made in the end of the fifth week after the experimental surgery. Human BM- 
MSCs were stained with antibodies against human β2-microglobulin, a very species-specific cell surface marker. 
Cell nuclei were stained with DAPI. 
 
cells from inflammatory cells, and therefore, cell-based immune response.  Such implant design 
targeted the long-term cell survival within the gel and provided space and adhesion surface for 
an expansion of transplanted MSCs. MSCs secreted a wide array of angiogenic factors, including 
VEGF, and promoted local angiogenesis in the muscles of the hind limb.  
In the gels with aligned pores cells were adhering and migrating within the channels 
along the long axis of the gel forming parallel cords of cells (Figure 21A). Cell adhesion was 
induced by RGD-peptides presented by alginate-based scaffold of the implants. MSCs in the gels 
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with random pores were confined to enclosed spaces of individual pores, where they were tightly 
packed and unable to expand into the adjacent pores because of low pore interconnectivity. High 
cell density likely led to excessive and premature cell death in the gels after transplantation. 
 When MSCs were encapsulated in the gel with IFNγ PLGA microparticles, they secreted 
25% more VEGF compared to the group with without interferon γ (Figure 21B). Thus, the 
presence of interferon γ in an implant significantly increased the amount of released VEGF over 
a two week period. This observation should be attributed to the fact that interferon γ as an 
inflammatory cytokine induces VEGF expression in MSCs [18]. At the same time the presence 
of interferon γ in the gels with randomly distributed pores was able to augment VEGF secretion 
by only 7%. Such difference in VEGF secretion profile between gels of different internal 
geometry can be attributed to reduced viability and proliferation of MSCs in the gels with 
random pores.  
In order to probe for their angiogenic potential, the gels were implanted into a mouse 
model of hind limb ischemia.  This model allows rapid evaluation (4-6 weeks) of 
revascularization after the ligation of the femoral artery. Such surgical intervention reduces 
blood flow by approximately 90% to the operated limb creating local ischemia, which is 
accompanied by mild myofiber degeneration/ necrosis and acute inflammatory changes [11, 22-
24]. At the end of the follow-up period, the mice with implanted gels and aligned pores exhibited 
less constrained movements in their left limb regardless of the presence of interferon γ. 
According to LDPI measurements, both groups had nearly 2-fold improvement in perfusion 
compared to the mice with cell-free implants with aligned pores. Thus, the presence of MSCs in 
the implant was crucial for re-establishing of blood supply in an ischemic limb. Interestingly, 
there was no significant difference between conditions when interferon γ was absent. PLGA 
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microparticles normally disintegrate in the animal tissues within 2 weeks after implantation. It is 
likely that interferon γ had no desired effect on MSC when the gels were implanted into animal 
tissues because of low concentration or additional unknown effects of IFNγ that may have 
counterbalanced the pro-angiogenic action of interferon on MSCs [25-26].  
The cell-laden gels with random pores and interferon γ failed to demonstrate an effect 
equal to the gels with aligned pores. The perfusion was 1.5 times less in the group with non-
aligned gels (Fig. 23). Low cell survival and reduced vital space in such gels may be responsible 
for less efficient blood perfusion recovery. This conclusion can be corroborated by a fact that the 
gels with random pores had only a marginal advantage over implantation of cell-free gels in 
terms of induced vessel density and total vessel area (Figure 24B and B).  
After five weeks implants remained mainly intact and were able to maintain their internal 
geometry (Figure 25).  Cell-free gels contained moderate amounts of newly deposited fibrous 
connective tissue infiltrated by macrophages mixed with few lymphocytes, whereas cell-laden 
gels contained free spaces occupied by only a few host cells. Such difference with cell-free gels 
may be attributed to the action of MSCs, which have been reported to reduce chronic 
inflammation [15, 27] and contribute to wound healing. The most noteworthy finding was a 
significant difference in the incidence of neutrophilic exudates between the interferon-
incorporating and interferon-free gels. Besides interferon’s action on MSCs that increases VEGF 
release, this cytokine also probably exerts certain effects on tissues surrounding the implant. One 
such function might be the typical activation of phagocytosis by macrophages [28]. Moreover, 
interferon γ reduces the number of neutrophils in the skin wounds and decreases the amounts of 
deposited collagen ameliorating consequences of local inflammation following tissue injury [25-
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26].  Thus, the incorporation of interferon γ in the implants may help decrease the active 
inflammatory response to the implant biomaterial or encapsulated cellular product.  
Our results demonstrate that MSCs only survived in an implant lacking IFN γ. IFN γ 
induces the classical pathway of macrophage activation and stimulates TH1 response responsible 
for cell-mediated immunity, which is often implicated in graft rejection [29]. It is possible that 
detected MSC grafts were accidentally shielded from the immune response by a focally intact 
alginate scaffold because the foci of live MSCs were found only in an implant of a single animal. 
  
4.5 Conclusion 
 Overall this study demonstrates a novel bio-patch design for correction of local tissue 
ischemia. Aligned pores within alginate-based implant provided vital space for human 
mesenchymal stem cell proliferation and expansion. The human MSCs were encapsulated in the 
gels for long-term angiogenic factor release, including VEGF. MSCs within implants were 
shielded from cell-based immune response by an alginate cap that prevented the migration of 
inflammatory cell inside the implant in the beginning of the experiment. And finally, interferon γ 
was incorporated in the bio-implants for augmentation of VEGF production by MSCs. Interferon 
γ increased VEGF expression by MSCs when tested in vitro, and had no significant effect on re-
vascularization; however it may have reduced the neutrophilic inflammation in the areas 
immediately adjacent to the implant in vivo. We suggest that cell-laden bio-patches with aligned 
pores will be effective for treatment of such conditions, as peripheral artery disease, when 
combined with interferon γ-therapy for reduction of local implant-induced inflammation.  
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Chapter 5: Summary and Future Directions 
5.1 Summary 
 In this work, I tried to re-examine the effects of matrix stiffness and, in part, geometry on 
the behavior and functions of pluripotent cells and tissue-specific cells in vitro as well as 
functional improvements in a mouse model of hind limb ischemia in vivo, after implantation of 
biomaterial patches laden with bone marrow-derived mesenchymal stem cells. The mechanical 
stiffness of the matrix determines forces bringing the cells together or separating them apart by 
controlling the mutual adhesion and migration and regulating three-dimensionality of tissue. 
Here, I demonstrated an increased cardiomyogenic and endothelial differentiation in mouse ES 
cells on a matrix exhibiting the stiffness of a normal mouse heart as a result of embryoid body 
(EB) attachment and preservation of 3D structure. Moreover, the physiological matrix stiffness 
allowed co-differentiation of ES cells into sheets of cardiac muscle with ingrown blood vessels 
resembling the normal developmental process. Next, I created a biomaterial system for testing 
the response of airway smooth muscle cells to a change in matrix stiffness. Airway SMCs are at 
the epicenter of pathogenesis of such pulmonary conditions, as asthma and emphysema, because 
of their involvement in regulation of airway diameter and secretion of VEGF. Asthma and 
emphysema are accompanied by a significant change in the stiffness of airways. Therefore, I 
described a model elucidating the general principles of airway SMC behavior on matrices with 
varying stiffnesses as it pertains to calcium signaling, VEGF secretion, proliferation and integrin 
expression. And finally, I put to the test the experience in cell-matrix interactions gained from 
experiments in vitro in an in vivo experiment for recovery of blood circulation in an ischemic 
limb of a mouse model. For stimulation of local angiogenesis, I construct a biopatch from 
alginate gel with incorporated MSCs and IFN γ-PLGA microparticles. The greatest positive 
109 
 
effect on blood perfusion recovery was observed in animals that received implants containing 
aligned microchannels with laden MSCs regardless of IFNγ presence. Thus, the biopatches with 
aligned microchannels may be more beneficial as a vehicle for stem cell delivery likely because 
they facilitate diffusion and provide living space for cells to expand.  
Overall, this work has laid a foundation for further tailoring of cell behavior through the 
mechanical stiffness of the matrix with the goal of building complex tissues in vitro.  Then, it 
demonstrated how this biomaterial system could be used for understanding of natural 
pathological processes, such as asthma and emphysema. And finally, the theoretical basis from 
the first two in vitro experiments was used in the design of a translational approach for cell 
therapy of hind limb ischemia in mouse model.   
 
5.2 Future directions 
 The results of this work can be used for the future projects in areas of developmental 
biology, in vitro organogenesis, regenerative medicine, and also for creation of clinically 
relevant toxicological assays. As our understanding of living cells grows, the medicine will 
gradually re-balance towards more complex treatment strategies that will include three-
dimensional cellular models and cell therapies. During that time the importance of physical 
environment, including the mechanical stiffness of the matrix, will come to the fore, because it 
will allow modulating cell behavior and organizing cells into cell therapy products.  
 Modulating the ES cell differentiation within EBs via changing the matrix stiffness is 
most promising for the in vitro organogenesis from pluripotent cells. This is a unique property of 
all pluripotent cells to spontaneously unfold their genetic program and form a tissue or an organ 
with all the complexity of cell types, ECM and architectural detail. Artificial scaffolds with 
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physiological stiffness can be used to regulate the differentiation of EBs and emulate the normal 
embryological development with the goal of creating intact individual organs originating from 
corresponding embryological buds. In such cases, the matrix with adjustable stiffness will play 
the role of adhesion substrate as well as of a differentiation inducer. Because matrix stiffness has 
an impact on cell proliferation and differentiation, it can be adjusted in such a way, that it will 
promote co-differentiation of several cell lineages in shape and form required by the investigator. 
Thus, it will be possible to engineer complex organs from ES-derived cells via modulation of 
matrix stiffness and geometry. Another approach could be to use, completely biodegradable 
scaffolds, which will be fully replaced with naturally deposited ECM by constituent 
differentiated cells. 
 The findings concerning the biology of airway smooth muscle cells that were done in this 
thesis will help understand the biology of asthma and emphysema. For example, further 
investigation of factors responsible for a change in VEGF secretion profile of airway SMCs 
could be important for clarifying the mechanisms involved in dysregulation of VEGF signaling 
in emphysema and asthma [1-2] and in change of mechanical qualities of airways [3-7]. 
Particularly the connection between the stiffness of airways, β1integrin expression, phosphor-
ILK and VEGF secretion seem to be interesting, because it establishes a pathway for matrix 
stiffness sensing and VEGF secretion by the airway SMCs. Increased larger airway vascularity in 
asthma and chronic bronchitis could be attributed to the effects of airways smooth muscle cells 
releasing large amounts of VEGF. At the same time, distorted by pathological processes airways 
stiffness may be implicated in a pathological change of VEGF production.  
 Finally, the understanding of cell-matrix interactions is important for the design of novel 
medical devices and biomaterial implants. Biomaterials can augment cell therapy treatments or 
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be used for therapy on their own. In the future, the application of implants from biomaterials 
with physiological stiffness and aligned microchannels for cell delivery will be more 
advantageous. Additional studies would be necessary to characterize the long-term survival and 
engraftment of therapeutic cells. Additionally, further clarification of IFNγ function in anti-
inflammatory effects and reduction of neutrophilic exudates near the cell-laden alginate implants 
would build a sound base for the use of this active molecule in combination with any future cell-
based  therapies.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
112 
 
5.3 References 
 
1. Lee, C.G., et al., Studies of vascular endothelial growth factor in asthma and chronic 
obstructive pulmonary disease. Proc Am Thorac Soc, 2011. 8(6): p. 512-5. 
 
2. Voelkel, N.F., R.W. Vandivier, and R.M. Tuder, Vascular endothelial growth factor in 
the lung. Am J Physiol Lung Cell Mol Physiol, 2006. 290(2): p. L209-21. 
 
3. Bosse, Y., et al., Increase in passive stiffness at reduced airway smooth muscle length: 
potential impact on airway responsiveness. Am J Physiol Lung Cell Mol Physiol, 2010. 
298(3): p. L277-87. 
 
4. Liu, F., et al., Feedback amplification of fibrosis through matrix stiffening and COX-2 
suppression. J Cell Biol, 2010. 190(4): p. 693-706. 
 
5. Liu, F. and D.J. Tschumperlin, Micro-mechanical characterization of lung tissue using 
atomic force microscopy. J Vis Exp, 2011(54). 
 
6. McGee, K.P., et al., Magnetic resonance assessment of parenchymal elasticity in normal 
and edematous, ventilator-injured lung. J Appl Physiol, 2012. 113(4): p. 666-76. 
 
7. Yuan, H., et al., Effects of collagenase and elastase on the mechanical properties of lung 
tissue strips. J Appl Physiol, 2000. 89(1): p. 3-14. 
 
 
 
